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ABSTRACT OF DISSERTATION 
 
 
 
MODULATION OF ENDOTHELIAL CELL ACTIVATION BY  
OMEGA-6 AND OMEGA-3 FATTY ACIDS 
 
Endothelial activation is considered to be an early and critical event in the 
pathology of atherogenesis which can be modified by environmental factors such as diet, 
pollutants, and lifestyle habits.  Dietary ω-6 and ω-3 fatty acids have been reported to 
either amplify or diminish inflammatory responses related to atherosclerosis development.  
However, the interactions of ω-6 and ω-3 fatty acids with inflammatory cytokines or 
organic pollutants on endothelial cell activation are not well understood.  The studies 
presented in this dissertation tested the hypothesis that ω-6 and ω-3 fatty acids alone, or 
in varying ratios can differently modulate pro-atherogenic mediators and inflammatory 
responses that are initiated by tumor necrosis factor- α (TNF-α) or polychlorinated 
biphenyls (PCBs) in endothelial cells.  Exposure to TNF-α induced oxidative stress, p38 
MAPK, NF-κB, COX-2 and PGE2, which was amplified by pre-enrichment with linoleic 
acid but blocked or reduced by α-linolenic acid.  Furthermore, TNF-α-induced caveolin-
1 up-regulation and the co-localization of TNF receptor-1 with caveolin-1 was markedly 
increased in the presence of linoleic acid and diminished by α-linolenic acid.  Silencing 
of the caveolin-1 gene completely blocked TNF-α-induced production of COX-2 and 
PGE2 and significantly reduced the amplified response of linoleic acid plus TNF-α.  
These data suggest that omega-6 and omega-3 fatty acids can differentially modulate 
TNF-α-induced inflammatory stimuli and that caveolae and its fatty acid composition 
play a regulatory role in these observed metabolic events.  Besides cytokines, lipophilic 
environmental contaminants such as PCBs can also trigger inflammatory events in 
endothelial cells.  Our data suggest that increasing the relative amount of α-linolenic acid 
to linoleic acid can markedly decrease oxidative stress and NF-κB-responsive genes.  The 
inhibitor study revealed that the modulation effect of ω-6 and ω-3 fatty acids on PCB 
toxicity was mainly through the oxidative stress sensitive transcription factor, NF-κB.  In 
conclusion, our studies demonstrate that different dietary fats can selectively modulate 
vascular cytotoxicity caused by TNF-α as well as by persistent organic pollutants such as 
PCBs.  We also demonstrated the important relevance of substituting dietary ω-3 fatty 
 
 
 
  
acids such as α-linolenic acid for ω-6 fatty acid such as linoleic acid in reducing 
cardiovascular diseases.  
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Chapter One : Introduction  
Endothelial Cell Activation and Atherosclerosis 
Cardiovascular disease is the number one killer worldwide, including in the 
United States.  For example, from the United States Chronic Disease Overview (1999), 
cardiovascular disease is responsible for more than 30 percent of all the deaths in the 
United States, which is more than all forms of cancer which is 23 percent of deaths.  
Cardiovascular disease can refer to many different types of heart or blood vessel 
problems and atherosclerosis is the generally the cause of all these problems.  
Atherosclerosis is an inflammatory disease of the vessel wall which predominantly 
involves endothelium and vascular smooth muscle layers of the arterial wall.  Vascular 
inflammation is a critical event in the pathogenesis of many human diseases, including 
atherosclerosis, hypertension, autoimmune diseases [1-3].  Progression of atherosclerosis 
can lead to the development of a plaque that is vulnerable to rupture and would then 
produce acute coronary syndromes, such as arterial thrombosis and myocardial infarction 
or stroke [4].   
Numerous risk factors associated with atherosclerosis have been identified, such 
as hypertension, diabetes mellitus, and dyslipidemia.  These particular cardiovascular risk 
factors commonly occur in obese individuals as components of the metabolic syndrome 
[5].  Furthermore, smoking, obesity, insulin resistance, hypertriglyceridemia, elevated 
levels of plasma cholesterol, low high-density lipoprotein, shear stress,  and oxidative 
stress can also increase the risk of atherosclerosis [6, 7].  A growing body of literature 
also indicates that environmental factors such as diet, lifestyle habit, and nutrition factors 
can play an important role in the development of atherosclerosis.  Substantial evidence 
from epidemiological studies suggests that cardiovascular diseases are linked to 
environmental pollution.  For example, there was a significant increase in mortality from 
cardiovascular diseases among Swedish capacitor manufacturing workers exposed to 
polychlorinated biphenyls (PCBs) for at least five years [8], and most excess deaths were 
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due to cardiovascular disease in power workers exposed to phenoxy herbicides and PCBs 
in waste transformer oil [9].   
Atherosclerosis depends critically on altered behavior of the intrinsic cells of the 
artery wall, in particular the endothelial cells.  Endothelial cells are constantly exposed to 
blood flow and are directly in contact with blood components.  These components 
include various kinds of cells, cytokines, toxic wastes, and dietary nutrients which might 
be accompanied with environmental pollutant.  In healthy condition, endothelial cell 
surface of the lumen is non-adhesive and anti-thrombogenic.  But in certain diseases, 
endothelial cell activation has been considered to trigger the initial development of 
atherosclerosis which involves the development of numerous oxidative and inflammatory 
reactions and will result in lymphocyte and monocyte adhesion to the vascular 
endothelium [10].  Oxidized LDL is one of the important triggers for the formation of the 
atherosclerotic lesion.  It may enhance migration and localization of inflammatory cells 
including T lymphocytes, monocytes, and macrophages [11].  Up-regulation of adhesion 
molecules on the surface of endothelial cells is prominent when they are exposed to pro-
inflammatory molecules such as tumor necroses factor-α (TNF-α), interleukin-1β (IL-
1β), interferon-γ (IFN-γ), platelet-derived growth factor (PDGF), and vascular endothelial 
growth factor (VEGF) [12, 13].  In sites of inflammation, leukocytes will migrate across 
activated endothelium.  This is a three-step process: the first step is the rolling of 
leukocytes on the endothelium which is mediated by selectins and addressins [14]; the 
second step is the attachment of leukocytes to the endothelium which is mediated by 
vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 
(ICAM-1); the third step is the transmigration of leukocytes across the thin layer of 
endothelial cells [15, 16].  Accumulation of monocytes in vascular subendothelial spaces 
and their conversion into lipid-laden “foam cells” is an early and important event in 
atherosclerosis [17].  Severe endothelial cell activation and injury can lead to necrotic and 
apoptotic cytotoxicity, and ultimately to disruption of endothelial integrity. 
Overall, the inflammatory reaction in endothelial cells is mediated by complex 
interactions between circulating nutrients, cytokines and environmental pollutants.  
Research in the current dissertation is trying to address the effects of dietary essential 
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omega-6 or omega-3 fatty acids on pro-inflammatory cytokine tumor necrosis factor-α 
(TNF-α) and environmental contaminant PCB77 on the activation of endothelial cells.   
 
Dietary Fatty Acids and Atherosclerosis 
Prospective and cross-sectional studies indicate that the dyslipidemia, insulin 
resistance and type 2 diabetes is an important contributor to atherosclerotic disease [18].  
The chronic elevation of serum free fatty acids, also referred as albumin-bound non-
esterified fatty acids is important component of the dyslipidemia and have been found to 
be associated with metabolic risk markers for coronary heart disease [19] and increased 
risk of cardiovascular diseases [20] .  The composition of intracellular non-esterified fatty 
acids pool is affected by the concentration of exogenous fatty acids.  The albumin-bound 
fatty acid can originate from distal lipolysis of triglycerides from adipose tissue and focal 
lipolysis of the triglycerides of VLDL and chylomicrons.  During the postprandial period 
albumin-bound free fatty acids mainly come from hydrolysis of triglyceride-rich 
lipoproteins of intestinal origin by the lipoprotein lipase.   
Diets high in omega-6 fatty acids have been shown to increase the risk of 
cardiovascular diseases.  In contrast, due to the low rates of coronary heart disease in 
Greenland Eskimos and Japanese who are exposed to a diet rich in fish oil, the beneficial 
effects of omega-3 fatty acids on cardiovascular health have been well documented.  The 
major dietary sources of omega-6 and omega-3 fatty acids are listed in Table 1.  Linoleic 
acid, the major omega-6 fatty acids in the American diet, is considered to be pro-
inflammatory and pro-atherogenic as it favors oxidative modification of LDL cholesterol, 
increases platelet response to aggregation, and suppresses the immune system [21].  
While, omega-3 fatty acids from fish oil have been shown to markedly reduce mortality 
from cardiovascular diseases [22-24].  Furthermore, a higher intake of α-linolenic acid 
which is enriched in vegetable oil has also been shown to inversely associate with risk of 
myocardial infarction [25] and carotid atherosclerotic disease [26].  In vitro studies also 
have shown that omega-3 fatty acids can down-regulate the expression of vascular 
adhesion molecules in endothelial cells [27].  There is evidence that intake of omega-3 
fatty acids are reflected in the concentration of these fatty acids not only in serum 
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phospholipids [28], but also in serum non-esterified fatty acids [28, 29]. In addition, 
accumulation of linoleic acid can affect endothelial cell lipid pools [30, 31].  However the 
primary mechanisms of the beneficial effects of dietary omega-3 especially α-linoleic 
acid on endothelial cell activation and the interaction of omega-3 with omega-6 fatty 
acids have not been well studied yet.  The human body can convert 18 carbon fatty acids 
into their 20 or longer chain derivatives via elongation and desaturation reactions.  In the 
current study, we focused on the 18-carbon linoleic acid and α-linolenic acid because 
they are the major parental essential fatty acids for the omega-6 and omega-3 fatty acid 
families, respectively, and are more sufficient in the human diet than their longer chain 
derivatives.   
 
Pro-Inflammatory Cytokine TNF-α-Stimulated Endothelial Activation 
Tumor necrosis factor (TNF) was isolated in 1984 and was named after its ability 
to cause tumor necrosis or regression in patients whose tumor has become infected with a 
bacterial infection [32, 33].  TNF is also referred to as TNF-α, cachectin, or 
differentiation-inducing factor (DIF) [34].  TNF-α can cause necrotic cell death, and may 
also cause apoptotic cell death, cellular proliferation, differentiation and inflammation.  
TNF-α is produced mostly by activated macrophages and monocytes, but also by many 
other cell types including B lymphocytes, T lymphocytes and fibroblasts [35].  Fig.1.1 
adapted from MacEwan et al [35], shows TNF mediated cellular responses.   
TNF-α, a trimeric 17-kd cytokine, is one of the most potent pro-inflammatory 
cytokines [36, 37] which is highly expressed throughout the full spectrum of 
atherosclerotic development [38].  TNF-α has numerous pro-inflammatory and 
procoagulant effects on endothelial cells [39].  It can stimulate production of reactive 
oxygen species (ROS) through induction of enzymes such as xanthine oxidase, COX, and 
nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) oxidase as well as 
other sources [40].  TNF-α increases recruitment of inflammatory cells to vascular lesion 
sites [39], and promotes vascular smooth muscle cell adverse remodeling and plaque 
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rupture [41].  Further, it promotes matrix degradation [42], thus facilitate influx of 
inflammatory cells to the vessel wall.   
TNF-α effects on endothelial cells include protein synthesis-independent changes 
in cell shape and motility that may contribute to vascular leakage at sites of inflammation 
as well as expression of new proteins that may regulate other parameters of the 
inflammatory response such as vasoregulation (e.g., COX-2 and GTP cyclohydrolase I), 
leukocyte adhesion (e.g., E-selectin, ICAM-1, VCAM-1), leukocyte activation 
(chemokines such as IL-8 or MCP-1), and coagulation (tissue factor and PAI-1).  TNF-α 
may also selectively turn off synthesis and eventually expression of some proteins such 
as thrombomodulin or eNOS.   
TNF-α engagement of TNF receptor-1 (TNFR-1) recruites the adaptor proteins 
TRADD, TRAF-2 into lipid rafts and activates NF-κB and MAPK pathways [43, 44]. 
Two specific transcription factors, NF-κB and activator protein-1 (AP-1) are essential for 
TNF-α induction of adhesion molecules.  E-selectin, ICAM-1, and VCAM-1 genes each 
contain DNA sequences in their 5’ flanking regions that bind various forms of NF-κB 
and AP-1 and that mutations of these sequences reduce TNF-caused these adhesion 
molecule up-regulation [45].  NF-κB is a DNA binding factor that can be activated by 
several inflammatory mediators such as TNF-α, interferon (IFN)-β, interleukin (IL)-8, 
IL-1β, IL-2, and IL-6 [46, 47].  The NF-κB complex consists of two heterodimers, p50 
and p65.  The activation of NF-κB requires the phosphorylation of NF-κB-inhibitor IκBα 
and then free NF-κB dimmers can translocate into nucleus, bind to the promoter regions 
of target genes, and induce transcription [47].   
Besides the induction of adhesion molecules, most of cellular, tissue, and 
systemic responses to TNF-α can be ascribed to TNF-α-induced PGE2 release.  
Prostanoids are lipid-derived mediators involved in various homeostatic and 
inflammatory processes through out the body.  The biosynthesis of prostanoids involves 
three enzymatic reactions including phospholipase A2 (PLA2) which liberates arachidonic 
acid (AA) from the sn-2 position of cellular membrane phospholipids, cyclooxygenase 
(COX) which converts AA to the endoperoxide intermediate Prostaglandin H2 (PGH2).  
PGH2 is subsequently converted to prostanoids by the action of cell-specific synthases 
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which are also called terminal prostaglandin synthases [48].  After the formation, 
prostanoids are released from the cells and act on their cognate receptors on cell surfaces 
to exert their biological actions. Prostaglandin E2 (PGE2) which PGE synthase is the most 
common prostanoids that can be produced by a wide variety of cells and tissues and has a 
broad range of bioactivity.  There are four types of PGE receptor, EP1, EP2, EP3, and 
EP4 [49].   
In the current study, we tested the hypothesis that omega-6 and omega-3 fatty 
acids can differentially modulate TNF-α-induced endothelial cell activation via oxidative 
stress-sensitive transcription factor NF-κB signaling pathway, thus influence the 
inflammatory mediator PGE2 synthesis.   
 
Significance of Caveolae in Fatty acids and TNF-α Mediated Endothelial Cell 
Activation 
In the 1950s the membrane invaginated vesicles of 50 to 100 nm were observed 
by electron microscopy, which were given the name of caveolae due to their cave-like 
appearance [50].  After the identification of caveolin, the signature protein of caveolae, 
caveolae have been implicated to be important in a variety of cellular functions including 
endocytic processes, cholesterol and lipid homeostasis, signal transduction, and tumor 
suppression [51].  Fig.1.2 shows the organization of caveolae membranes as adapted 
from Razani et al [51]. 
Caveolae have been considered a specialized form of lipid raft [52].  But certain 
proteins have been found to preferentially partition into lipid rafts or caveolae but not 
both [53].  Furthermore, the localization caveolin proteins to caveolae distinguishes these 
membrane domains from lipid rafts [51].  Forty years after the definition of caveolae, the 
22-kDa protein caveolin was isolated and subsequently cloned [54, 55].  There are three 
gene family members of caveolin: caveolin-1, -2, and -3.  Adipocytes, endothelial cells, 
pneumocytes, and fibroblasts have the highest levels of caveolin-1 and -2 [56, 57], 
whereas caveolin-3 expression is limited to muscle cell types [58]. 
Numerous roles have been attributed to caveolae proteins: vesicular transport [59], 
cellular cholesterol homeostasis [60], oncogenes and tumorigenesis [61], and signal 
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transduction mechanisms [62, 63].  Several lines of research suggest that caveolin family 
members function as scaffolding proteins [64] to concentrate and organize specific lipids, 
such as cholesterol and sphingolipids [60, 65] and lipid-modified signaling molecules 
within caveolae membranes [66-68].   
Cholesterol and glycosphingolipids are essential components of caveolae.  Sterol-
binding agents can bind to cholesterol and disrupt caveolar structure [69].  Also, utilize 
cholesterol oxidase which reduces cellular cholesterol can cause the translocation of 
caveolin-1 from the plasma membrane to intracellular membrane compartments [70].  
Consequently, changes in the lipid component of caveolae membranes can potentially 
result in profound changes in caveolar functioning.  Thus, caveolae lipids are important 
for organizing and regulating the molecular interactions of multiple signaling pathways.   
Gafencu et al [71] investigated fatty acid composition of caveolae from 
endothelial cells  and indicated that palmitic acid (16:0), palmitoleic (16:1), stearic acid 
(18:0), and oleic acid (18:1) were most prevalent which compose the 80% of total fatty 
acids, linoleic acid (18:2) was about 8 to 10% of total fatty acids.  Omega-3 fatty acids 
have been shown to alter caveolae microenvironment, thereby modifying location and 
function of proteins in caveolae.  Eicosapentaenoic acid (EPA) induces displace caveolin-
1 from caveolae in endothelial cells [72] and omega-3 fatty acid feeding reduces both 
cholesterol and caveolin-1 in mouse colon [73].  EPA and docosahexaenoic acid (DHA) 
have also been shown to decrease lipid raft sphingomyelin, cholesterol content [74] and 
to selectively alter subcellular distribution of cytosolic proteins, including Ras isoforms, 
by modifying membrane lipid composition [75].  Furthermore, H-Ras has been shown to 
target to the plasma membrane and caveolin is crucial for the function of H-Ras [76].   
Caveolin-1 can bind to many types of plasma membrane receptor proteins or 
membrane associated enzymes and concentrate these molecules within caveolae [51].  
Fatty acid translocase (FAT/CD36), a major protein associated with fatty acid uptake [77], 
is preferentially located in the caveolae at the plasma membrane level [78].  TNFR-1 has 
been reported to concentrated within the caveolae of a human endothelial cell line [79].  
Interleukin-1β-induced COX-2 in human fibroblasts is colocalized with caveolin-1 [80].  
Previous studies demonstrated that in the absence of ligand, PDGF is associated with 
rafts, and in the presence of ligand, it transiently associates with caveolae [81].   
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It has been widely accepted that binding of TNF-α to monomeric receptors results 
in receptor trimerization and that this ligand-induced receptor clustering causes 
recruitment of specific adapter signaling proteins to intracellular domains of receptors 
that have been incorporated into these ligand-receptor complexes [82].  There are two 
types of TNF receptor: TNFR-1 and TNFR-2.  The TNFR1 is expressed on all cell types 
including endothelial cells and is better understood, while the TNFR2 is mainly 
expressed on cells of the immune system.  TNFR-1 contains a death domain, termed 
TNFR-associated death domain (TRADD) which is recruitment at the plasma membrane, 
and this region is required for TNF-α-induced pro-inflammatory cellular responses, such 
as activation of nuclear factor κB (NF-κB) [34].  In promonocyte cell line U937, if the 
caveolae like domains are disrupted, the surface expression of TNFR-1 and CD36 are 
significantly reduced [83].  The p38 MAPK pathway is activated by hydrogen peroxide 
and UV light [84, 85].  p38MAPK, but not p42/44 is a critical component of the oxidant 
stress (H2O2)-sensitive signaling pathways [85].  Phosphorylation of caveolin-1 occurs 
specifically through activation of the p38 MAPK [86].  Activation of MAPKs has also 
been shown to associate with subcellular redistribution of caveolin and cholesterol [87]  
Caveolin-1 has been proposed to be essential in a variety of cellular functions.  
Caveolin-1 knockout mice revealed that caveolin-1 is not essential for maintaining life 
but plays an important role in vascular functions [88, 89].  Both in vivo and in vitro 
experiments demonstrated that caveolin-1 is essential for caveolae formation and 
interacts with a variety of signaling molecules in endothelial cells, suggesting that 
caveolin-1 may be an essential signaling platform.  In the current study, we tested the 
hypothesis that omega-6 and omega-3 fatty acids can differentially modulate TNF-α-
induced endothelial cell activation and that functional caveolae are required for 
endothelial cell activation.  TNF-α-induced proinflammatory signaling pathways were 
analyzed under experimental conditions with intact caveolae and with cells in which 
caveolin-1 was silenced by siRNA.  
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PCB-Induced Endothelial Cell Activation 
Polychlorinated biphenyls (PCB) are produced by chlorination of biphenyl and 
comprise a class of 209 individual compounds, depending on the position of chlorine 
atom substituents.  The commercial use of PCBs started in the late 1920s including fluids 
in transformers, capacitors and hydraulic transfer systems, plasticizers in paints, dyes, 
plastics and rubber products etc. [90].  The total amount produced world-wide is 
estimated at 1.5 million tons.  PCBs have non-flammability, chemical stability and high 
dielectric constants.  
More than 90% of human PCBs exposure derives from food and PCBs are poorly 
metabolized and tend to accumulate in animal tissues, including humans.  The 
accumulation particularly in tissues and organs rich in lipids appears to be higher in the 
case of penta and more highly chlorinated biphenyls.  Studies have revealed PCBs in 
human fat tissue and blood plasma. [91-93].  Scientific Cooperation (EU SCOOP Task 
3.2.5 June 2000) reported that the main contributors to the daily dietary exposure dioxins 
appear to be fish and fish products (11-63%); meat and meat products (6-32%), milk and 
diary products (16-39%).  Following exposure to animals, PCB will accumulate in meat, 
liver and particularly in fat tissues.  PCBs build up (bioaccumulation) in the environment, 
increasing in concentration as you move up the food chain. This is of special concern in 
areas where fish are exposed to PCB contamination and may be consumed by humans (as 
in the Hudson River).  
PCBs were banned by the EPA in 1979, and are classified as a probable human 
carcinogen by numerous national and international health-protective organizations, such 
as the EPA, The Agency for Toxic Substances and Disease Registry (an arm of the U.S 
Public Health Service) and the World Health Organization. Research also links PCB 
exposure to developmental problems. 
Numerous experimental and epidemiological studies have demonstrated that 
environmental pollution is strongly involved in the pathogenesis of atherosclerosis.  
Endothelial cells directly contact with blood substances which include environmental 
pollutant.  Certain polyhalogenated aromatic hydrocarbons can cause endothelial cell 
activation, thus can be implicated in atherosclerotic lesion formation [94, 95].  Coplanar 
PCBs, such as PCB77 can induce oxidative stress through the aryl hydrocarbon receptor 
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(AhR)-cytochrome P450 1A1 (CYP1A1) pathway [96].  Induction of CYP1A1 is 
considered cardiotoxic through generating reactive oxygen species (ROS).   
Previous studies have shown that environmental contaminants such as PCBs can 
be implicated in atherosclerotic lesion formation [97, 98].  We have previously reported 
that coplanar polychlorinated biphenyl (PCBs) such as PCB77 can induce inflammatory 
genes VCAM-1 and IL-6 in vascular endothelial cells [96, 99].  PCBs can significantly 
activate CYP1A1 enzyme [100].  PCB77, a coplanar PCB, is a 3-methylcholanthrene-
type cytochrome P450 inducer and an aryl hydrocarbon receptor (AhR) ligand.  
Mechanisms of the interaction of ω-6 or ω-3 fatty acids and PCBs in endothelial 
cell activation are not clear.  Exposure to PCBs can change fatty acid composition of 
tissues like the liver with a proportional decrease in arachidonic acid and increase in oleic 
and linoleic acid [101, 102].  Long term exposure to PCBs have been shown to increase 
plasma triglycerides and decrease HDL-cholesterol [103].  In the current study, we tested 
the hypothesis that different types of dietary polyunsaturated fatty acids can selectively 
modify PCB-induced vascular endothelial cell activation and the mechanisms of PCB77-
induced inflammation can be modified by different ratios of omega-6 to omega-3 fatty 
acids.   
 
Hypothesis and Significance of the Current Study 
Previous studies have demonstrated that increasing levels of circulating cytokines 
such as TNF-α, environmental contaminants such as PCBs, or certain dietary nutrients 
such as omega-6 fatty acids can cause endothelial activation and promote an 
inflammatory response [6, 104, 105].  Furthermore, our previous data have shown that 
linoleic acid could potentiate inflammatory events induced by both TNF-α and PCBs 
[106, 107].  Most of these inflammatory events involve oxidative stress and result in the 
activation of oxidative stress sensitive transcription factors NF-κB or AP-1 which can 
consequently stimulate the expression of cytokines and adhesion molecules [108, 109].  
But the anti-atherogenic and anti-inflammatory effects of ω-3 fatty acids, in particular α-
linolenic acid, have not been investigated under these stimulations.  And the modulation 
effect of changing the relative amounts of omega-6 and omega-3 fatty acids on 
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environmental pollutant-induced endothelial cell activation has not been well elucidated 
yet.  It is possible that changes in the lipid (fatty acid) environment can alter the 
membrane lipid rafts, inflammatory mediators, cell signal transduction, and gene 
expression.   
This study investigated the effects of omega-6 and omega-3 fatty acids on TNF-α 
and PCB77-induced PGE2 release in endothelial cells.  This was accomplished by 
examining points of potential intervention in the cellular signaling cascades.  We 
explored the impact of these fatty acids alone, or at different ratios on TNF-α binding to 
TNFR-1, cytoplasmic phospholipase A2 activation, and COX-2 expression.  In addition, 
we explored their impact on the binding activity of NF-κB, and signaling pathways such 
as p38 MAPK.  
Research described in this dissertation provides a better understanding of the 
differential modulation effects by omega-6 and omega-3 fatty acids alone, or by changing 
the ratios of omega-6 to omega-3 fatty acids on endothelial cell activation induced by 
pro-inflammatory cytokine TNF-α or PCB77 and the underlying molecular mechanisms.  
There is a great need to further explore this nutritional paradigm in environmental 
toxicology and to improve our understanding of the relationship between nutrition and 
lifestyle, exposure to environmental toxins and disease.  Nutrition may provide the most 
sensible means to develop primary intervention and prevention strategies of diseases 
associated with many inflammatory and environmental toxic insults. 
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Table 1.1  Major dietary polyunsaturated fatty acids  
 
Dietary Fatty acids 
 
ω-6 or ω-3 families
 
Source 
 
linoleic acid (LA; 18:2) ω-6 fatty acid soy, corn, safflower, and 
sunflower oils 
arachidonic acid (AA; 20:4) ω-6 fatty acid animal products 
α-linolenic acid (ALA; 18:3) ω-3 fatty acid canola, walnut, and 
flaxseed oils 
eicosapentaenoic acid (EPA; 20:5)  ω-3 fatty acid fish oil 
docosahexaenoic acid (DHA; 22:6) ω-3 fatty acid fish oil 
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Figure 1.1  Major TNF receptor-mediated cellular responses 
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Figure 1.2  Organization of lipid rafts and caveolae membranes 
 
A, lipid rafts: the liquid-ordered phase is dramatically enriched in cholesterol and 
exoplasmic oriented sphingolipids (sphingomyelin and glycosphingolipids).  The lipid-
disordered phase is composed essentially of phospholipids (phosphatidylcholine, 
phosphatidylethanolamine, and phosphatidylserine).  B, caveolae: upon integration of the 
caveolin-1 protein, liquid-ordered domains form small flask-shaped invaginations called 
caveolae.  Caveolin-1 monomers assemble into discrete homo-oligomers containing ~14 
to 16 individual caveolin molecules.  Adjacent homo-oligomers are thought to pack side-
by-side within caveolae membranes thereby providing the structural meshwork for 
caveolae invagination.  Adapted from Razani et al. [51]. 
 
 
 
Copyright © Lei Wang 2007 
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Chapter Two : Effects of ω-6 and ω-3 Fatty Acids on TNF-α-Induced Endothelial 
Cell Activation 
Synopsis 
TNF-α, an important pro-inflammatory mediator of endothelial cell activation, 
can lead to the formation of lipid-derived prostaglandins.  Different ω-6 and ω-3 fatty 
acids have been implicated to have pro- or anti- inflammatory actions, respectively.  
However, the mechanisms of ω-6 and ω-3 fatty acids mediated TNF-α-induced 
production of the major inflammatory mediator prostaglandin E2 (PGE2) and the 
underlying signaling mechanism remains unclear.  The present study focused on the 
effects of ω-6 and ω-3 fatty acids on TNF-α-induced oxidative stress and the 
inflammatory signaling that involves in PGE2 production.  Porcine pulmonary-arterial 
endothelial cells were first enriched with linoleic acid (LA; 18:2 ω-6) or α-linolenic acid 
(ALA; 18:3 ω-3), followed by exposure to TNF-α.  TNF-α-induced oxidative stress, p38 
MAPK activation and activation of nuclear factor κB (NF-κB) were markedly increased 
in the presence of linoleic acid and diminished by pretreatment with α-linolenic acid.  
Similar protective effects of α-linolenic acid were observed by measuring COX-2 
expression and the production of PGE2.  Treatment with p38 MAPK specific inhibitor 
significantly decreased TNF-α-induced COX-2 and VCAM-1 protein expression.  Taken 
together, our data suggest that in endothelial cells, linoleic acid and α-linolenic acid can 
generate distinct signaling outcomes in response to inflammatory stimuli caused by TNF-
α and p38 MAPK plays an important role in fatty acid mediated TNF-α-induced 
inflammatory response.  
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Introduction  
Vascular endothelial dysfunction is thought to be involved in the initiation of 
atherosclerotic lesions.  Endothelial cells lying at the blood-tissue interface play an 
essential role in homeostasis of the circulation and vessels.  At normal state, endothelial 
cells have antithrombotic and anticoagulant activities [110].  But the “activation” of 
endothelial cells can cause changes to the hemodynamic equilibrium and the 
development of numerous oxidative and inflammatory reactions, which result in 
lymphocyte and monocyte adhesion to the vascular endothelium [10, 111].  This is 
considered to involve in the very early stage of atherogenesis.  Leukocyte adhesion to the 
endothelium is facilitated by the appearance of adhesion molecules at the surface of 
lymphocytes, monocytes, and endothelial cells.  These molecules are mainly selectins 
(e.g. E-selectins are specific to endothelial cells), vascular cell adhesion molecule type 1 
(VCAM-1), and intercellular adhesion molecule type 1 (ICAM-1) [112].   
One of the common mediators of endothelial cell activation is macrophage-
derived cytokines, such as tumor necrosis factor alpha (TNF-α) [113].  Patients with 
clinical cardiovascular disease had significantly higher levels of TNF-α compared with 
subjects without cardiovascular disease [114].  High levels of circulating TNF-α can 
cause endothelial cell activation resulting in the development of numerous oxidative and 
inflammatory reactions and facilitating lymphocyte and monocyte adhesion to the 
vascular endothelium [10, 111]. Furthermore, TNF-α profoundly affects eicosanoids 
metabolic pathways leading to the accumulation of one or more pro-inflammatory 
prostaglandins.   
The mechanisms by which selected fatty acids induce endothelial cell activation, 
oxidative stress and inflammation are not fully understood.  Oxidative stress-induced 
transcription factors, which regulate inflammatory cytokine and adhesion molecule 
production, are important regulatory elements in the induction of inflammatory responses.  
One of these transcription factors, nuclear factor κB (NF-κB), plays a significant role in 
these regulatory processes [115].  Binding sites for NF-κB and related transcription 
factors were identified in the promoter regions of a variety of inflammatory genes [116, 
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117] such as interleukin 6 (IL-6), vascular cell adhesion molecule-1 (VCAM-1) or 
cyclooxygenase-2 (COX-2), all of which are up-regulated by TNF-α [118, 119]. 
Numerous risk factors for the development of atherosclerosis have been identified, 
including obesity [120] and hypertriglyceridemia [121].  Increased circulating free fatty 
acid levels are associated with hypertriglyceridemia and obesity [122], and high plasma 
free fatty acids may contribute to an environment of increased oxidative stress and 
inflammation in the vasculature and especially in vascular endothelial cells [123, 124].  
Dietary balance of long-chain fatty acids may influence processes involving leukocyte-
endothelium interactions, such as atherogenesis and inflammation [125].  Even though 
diets high in omega-6 fatty acids may lead to a decrease in serum cholesterol [126], 
replacing saturated with unsaturated omega-6 rich lipids may not be desirable because of 
their ability to easily oxidize.  High intake of linoleic acid-rich oils or fats will lead to an 
increase in cellular oxidative stress and can elicit an inflammatory response [127], events 
which have been implicated in most chronic diseases.  Omega-6 fatty acids, and 
especially linoleic acid can cause endothelial cell dysfunction as well as potentiate tumor 
necrosis factor-α (TNF-α)-mediated endothelial injury [128].  We have recently 
demonstrated that both the extracellular signal regulated kinase (ERK1/2) and 
phosphoinositide-3 kinase/ amino kinase terminal (PI3K/Akt) signaling pathways can 
contribute to the effect of linoleic acid on nuclear factor-kappa B (NF-κB)-dependent 
transcription and endothelial cell activation [105].  
In contrast to omega-6 fatty acids, omega-3 fatty acids can influence 
cardiovascular disease pathology by beneficially modulating inflammation.  
Epidemiological and interventional studies have shown a dose-dependent decrease in risk 
of cardiovascular disease endpoints with increased dietary consumption of moderate 
amounts of omega-3 fatty acids, either plant or marine derived [126].  Current estimates 
indicate that over 90% of the omega-3 consumed by U.S. citizens is in the form of α-
linolenic acid, not the longer chain omega-3 fatty acids found in fish oils [129].  
Independent of their dietary source, omega-3 fatty acids contribute to cardio-protective 
properties, which include down-regulation of proinflammatory and proatherogenic genes, 
including adhesion molecules and cytokines, during early atherogenesis and possibly also 
during later stages of plaque development and plaque rupture [130].  For example, an α-
 17  
 
 
  
linolenic acid-rich oil decreased oxidative stress and CD40 ligand in patients with mild 
hypercholesterolemia [131], reduced levels of soluble cell adhesion molecules in plasma 
[132] and recurrence of coronary heart disease [133].  Also, by partially replacing omega-
6 analogues in membrane phospholipids with omega-3 fatty acids, it is possible to 
decrease the transcriptional activation of inflammatory and pro-atherogenic genes 
involved in endothelial cell activation and atherosclerosis [134].    
Previous studies in our laboratory have shown that linoleic acid potentiated TNF-
α–mediated pro-inflammatory responses in endothelial cells [107].  Linoleic acid may 
further be atherogenic by causing activation of NF-κB which in turn increases the 
expression of E-selectin and VCAM-1 [128, 135].  On the other hand, lipids are crucial 
structural and functional components of cells. Even more importantly, many lipid species 
have distinct cellular functions. For example, ceramides, eicosanoids, diacylglycerol 
(DAG) and lysolipids are all second messengers which participate in various cellular 
events such as inflammation, growth, proliferation, differentiation and cell death.  
However the primary mechanism of the modification of these different metabolism 
pathways by the availability of different series of omega-6 and omega-3 PUFAs in the 
presence of TNF-α is not well known. 
The present study was conducted to test the effects of linoleic acid and α-linolenic 
acid on TNF-α-induced prostaglandin E2 (PGE2) release in primary porcine pulmonary 
artery endothelial cells.  Three markers of inflammation, oxidative stress, p38 MAPK, 
COX-2 that have been recognized to play a role in atherogenesis, along with transcription 
factor NF-κB, were assessed.   
In the current study, we demonstrate that ω-3 fatty acid inhibits the ability of pro-
inflammatory cytokine TNF-α to induce the expression of adhesion molecules associated 
with endothelial cell activation.  We also show here that ω-3 fatty acid were associated 
with the inhibition of p38 MAPK signal transduction pathways.  These results provide 
new insights into the modulation of TNF-α-induced inflammatory responses by dietary 
polyunsaturated fatty acids.   
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Materials and Methods 
Cell culture and experimental media 
Endothelial cells were isolated from porcine pulmonary arteries and cultured as 
previously described [30] (see detailed protocol in Appendix B).  Arteries obtained 
during routine slaughter were donated from the College of Agriculture, University of 
Kentucky.  The basic culture medium consisted of medium 199 (M-199) (GIBCO 
Laboratories, NY) containing 10% (v/v) fetal bovine serum (FBS, HyClone Laboratories, 
UT).  The experimental media were composed of M-199 enriched with 5% (v/v) FBS and 
with linoleic acid (LA) or α-linolenic acid (ALA) (> 99% pure; Nu-Chek Prep, MN).  
Preparation of experimental media with LA and ALA were performed as described 
earlier [136] (see detailed protocol in Appendix B).  Metabolic studies [137] indicated 
that the molar ratio of free fatty acid to albumin is the main factor controlling free fatty 
acid availability to tissues.  In plasma, albumin concentration is about 600 μM, and total 
free fatty acid is 180 to 2000 μM thus the range of ratios of fatty acid to albumin is 0.3 to 
4.  In the experimental media, 20 μM fatty acids were enriched in 5% media with which 
the albumin concentration is about 50 to 60 μM.  So the ratio of free fatty acids to 
albumin is within physiological and metabolic relevance and not toxic to the cells.   
Human TNF-α was purchased from Sigma (Sigma-Aldrich, MO).  In the p38 
MAPK inhibitor study, SB203580 was dissolved in DMSO (Sterile-filtered, Sigma-
Aldrich, MO) to a stock solution of 10 mM.  After getting confluent, cells were first 
incubated with 10 μM of SB203580 (a thousand times dilution from stock solution) for 
30 min followed by exposure to TNF-α.  The control culture contained the same volume 
of DMSO. 
 
E-selectin, VCAM-1, and COX-2 gene expression studies 
RT-PCR: 
Total cellular RNA was extracted from culture plates according to the RNA-
STAT-60 protocol (TEL-TEST, Friendswood, TX).  RNA concentration was 
spectrometrically determined by reading the absorbance at 260 nm.  cDNA first strand 
was synthesized from total RNA by RT reaction.  The reaction mixture contained 1 μg 
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RNA.  Resulting cDNA was amplified by the polymerase chain reaction with enzyme 
nucleotides and buffers from Quiagen (Valencia, CA).  The following primers for E-
selectin, VCAM-1, and COX-2 were employed in the PCR.  E-selectin: forward 5’-
GACTCGGGCAAGTGGAATGATGAG-3’; reverse 5’-CATCACCATTCTGAGGATG 
GCCGAC-3’.  VCAM-1: forward 5’- GTTTACCCGGTTGAAAAGTTGGAG-3’; 
reverse 5’- CACCGTGTCG CCTGTCTCT-3’.  COX-2: forward 5’-GGAGAGACAGGC 
ATAAACTGC-3’, reverse 5’-GTGTGTTAAACTCAGCAGCA-3’.  β-actin was used as 
a house keeping gene: forward 5’- GGGACCTGACCGACTACCTC-3’; reverse 5’-GGG 
CGATGATCTTG ATCTTC-3’.  The PCR products were electrophoresed on a 2% (w/v) 
EDTA agarose gel.  Then stained with SYBR Green ( Molecular Probes, Eugene, OR) 
and visualized by using phosphorimaging technology (FLA-5000; Fuji, Stamford, CT).  
Real-time PCR: 
Total RNA was extracted from endothelial cells using RNA-STAT-60 (TEL-
TEST, Friendswood, TX) according to the manufacturer’s protocol.  Reverse 
transcription was performed using the AMV reverse transcription system (Promega, 
Madison, WI). The levels of mRNAs and the PCR-product were then assessed by real-
time PCR using 7300 Real Time PCR System (Applied Biosystems).  Real-time PCR 
samples were mixed with SYBR Green Master Mix (Applied Biosystems) and VCAM-1 
or COX-2 specific primers.  The sequences for porcine VCAM-1 and COX-2 gene were 
designed by Primer Express Software 3.0 for real-time PCR (Applied Biosystems).  
VCAM-1 sequences: sense, 5’-TGGAAAGACATGGCTGCCTAT-3’; antisense, 5’-
ACACCACCCCAGTCACCATA TC-3’.  COX-2 sequences: sense, 5’-TGCTGAAGCC-
CTATCGATCA-3’; antisense, 5’-TACAGCTCCATGGCATCAATG-3’.  β-actin was 
used as a housekeeping gene in both VCAM-1 and COX-2 studies.  β-actin sequences: 
sense, 5’-TCATCACCATCGGCAACG-3’; antisense, 5’-TTCCTGATGTCCACGTCG-
3’. 
 
Immunofluorescence study of E-selectin expression 
Confluent endothelial cells were grown on glass culture slides and incubated with 
or without TNF-α for 4 h.  After three washing in phosphate-buffered saline (PBS), cells 
were fixed by 70% ethyl alcohol for 10 min and air-dried.  After 30 min of blocking of 
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non-specific binding with PBS containing 3% BSA, cells were incubated with E-selectin 
primary antibody for 1 h on ice at a dilution of 1:50.  Then slides were washed twice in 
PBS then incubated simultaneously with FITC-labeled secondary antibody (1 h at room 
temperature, dilution 1:5; Chemicon, CA).  Negative controls were prepared by 
incubation of the cells with anti-IgG antibody.  The cells were washed twice in PBS and 
mounted in aqueous mounting medium before being observed using an epifluorescence 
Nikon Eclipse E600 microscope.  The images were capture using a Spot charge coupled 
device camera system (Nikon, Melville, NY). 
 
Measurement of cellular oxidative stress 
Cellular oxidation was determined by 2', 7'-dichlorofluorescein (DCF) 
fluorescence as described earlier [138].  This method is based on the conversion of 2’, 7’-
dichlorofluorescin into fluorescent 2’,7’-dichlorofluorescein by oxygen reactive species, 
primarily peroxyl radicals and peroxides.  Please find the detailed protocol in Appendix B.  
After treatment cells were washed with Hanks buffer to remove serum.  Then KREBS-
Ringer-Glucose buffer containing DCF (100 μmol/L) (Molecular Probes, Inc., Eugene, 
OR) were added to microplates and incubate for 30 minutes.  Blank well also received 
KREBS-Ringer-Glucose buffer without DCF probe.  Wrap plate in aluminum foil to 
protect from the light.  After incubation washed wells 2 to 3 times with HEPES buffer 
and then added HEPES to each well (1 ml for 12 well plates and 0.5 ml for 24 well plates.  
Wrap plate in aluminum foil before reading.  A multi-well fluorescent plate reader 
(Molecular Devices, Sunnyvale, CA) was utilized for the imaging study.  Excitation and 
emission wavelengths were 490 and 520 nm respectively.   
 
Transcription factor NF-κB activation studies: electrophoretic mobility shift assay 
(EMSA) 
Nuclear extracts containing active proteins were prepared from cells according to 
the method of Beg et al. [139].  Binding reactions were performed in a 20 μL volume 
containing 7 μg of nuclear protein extracts.  Nuclear extracts were incubated for 25 min 
with 32P-end-labeled oligonucleotide probes containing enhancer DNA element NF-κB 
(5’ AGTTGAGGGGACTTTCCCAGGC 3’) (Santa Cruz, Santa Cruz, CA).  Following 
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binding, the protein-DNA complexed and uncomplexed DNA in the mixture were 
resolved on native 5% polyacryamide gels using 0.5x TBE buffer (50 mM Tris-Cl, 45 
mM boric acid, 0.5 mM EDTA, pH 8.4) and visualized by autoradiography.  Control 
reactions using 200-fold molar excess of unlabeled oligonucletide probes or a supershift 
assay were performed to demonstrate the specificity of the shifted DNA-protein 
complexes for NF-κB. 
 
Measurement of VCAM-1 or COX-2 protein levels, and phosphorylation of p38MAPK or 
cPLA2 by western blot 
Cells were harvested using cell lysis buffer as previously described [105].  Protein 
samples were resolved by SDS-PAGE using 10% gradient gels and transferred 
electrophoretically to nitrocellulose membranes using a Bio-Rad immunoblot transfer 
apparatus (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s 
instructions.  The nonspecific sites on the membrane were blocked 1 h at room 
temperature with 5% nonfat dry milk in TBST followed by incubation with β-actin 
(1:5000 dilution in 5% nonfat milk), VCAM-1 (1:2000 dilution in 5% nonfat milk), 
COX-2 (1:2000 dilution in 5% nonfat milk), total p38 MAPK (1:1000 dilution in 5% 
nonfat milk), phosphor-p38 MAPK (1:1000 dilution in 5% nonfat milk), or phosphor-
cPLA2 (1:500 dilution in 5% nonfat milk) primary antibodies (Santa Cruz Biotech, CA) 
overnight at 4 °C.  Bands were visualized using the appropriate horseradish peroxidase-
conjugated secondary antibodies followed by ECL immunoblotting detection reagents 
(Amersham Biosci, UK).  Detection and quantitative analysis were performed using a 
digitizing system (UN-SCAN-IT, Silk Scientific Corporation).  To determine the optimal 
amounts of samples for linear area detection, a titration of different amounts of sample 
were loaded.  For COX-2 and VCAM-1, 30 μg protein were loaded; for p38 MAPK, 35 
μg protein were loaded; for phospho-cPLA2, 40 μg protein were loaded.   
 
PGE2 determination 
Cells were seeded in 60 mm petri dishes (Becton Dickinson Labware, NJ) and 
grown to confluence.  After treatment, supernatants of cell cultures were collected into 
microcentrifuge tubes (Isc BioExpress, UT), centrifuged at 4 ℃ to remove cellular debris 
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and stored at -80 ℃.  PGE2 levels were assessed using a PGE2-specific enzyme 
immunoassay (EIA) (Cayman Chemicals, MI) following the manufacturer’s protocol 
with minor modification (see detailed protocol in Appendix B).  A microplate 
spectrophotometer SpectraMaxPro M2 (Molecular Devices Corporation, CA) was used to 
read the plate at 405 nm.   
 
Statistical analysis 
Values are reported as mean ± standard error of the mean (SEM) of at least three 
independent groups. Data were analyzed using Sigma Stat software (Jandel Corp., Wan 
Rafael, CA). One way ANOVA followed by post hoc least significant difference (LSD)’s 
pairwise multiple comparison procedure were used for statistical analysis of the original 
data.  A statistical probability of p< 0.05 was considered significant.  In figures 2.4, 2.13, 
and 2.15, * indicates significant difference from control group.  In all the other figures, 
different letters represent significant differences among treatment groups.  Capital or 
small letters represent with or without TNF-α treatment respectively as were compared 
separately by one way ANOVA. 
 
 
Results  
Determination of optimal TNF-α concentration and incubation time for the stimulation of 
endothelial cell activation  
TNF-α is arguably the most potent inducer of a power pro-inflammatory cytokine.  
Previous epidemiological studies indicated that the plasma concentrations of TNF-α are 
increased in various pathological situations, and TNF-α levels vary widely not only 
among different diseases but also among different patients with the same disease.  For 
example, in diabetic patients TNF-α can reach 19.3±7.5 pg/ml in comparison with 
healthy controls (11.1±5.8 pg/ml) [140], or 228 pg/ml vs. 4.2 pg/ml [141].  Another 
study reported a median TNF-α level at 26 pg/ml in patients with sepsis, ranging from 0 
to 1000 pg/ml [142].  In patients with lymphoma, the TNF-α levels were between 5 to 
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380 pg/ml with the median of 20 pg/ml, and the healthy controls were between 4 to 9 
pg/ml with the median of 7 pg/ml [143].  Even when the plasma levels of TNF-α are 
known, local concentrations of inflammatory cytokines in the endothelial 
microenvironment are not well defined.  Some in vitro studies used relatively high 
concentration of TNF-α from 10 ng/ml [144] to 50 ng/ml [145].  For some apoptosis 
studies, TNF-α concentration also has been used at 50 ng/ml [146].   
In the current study, as we were concerning about the effects of fatty acids on 
inflammatory responses caused by TNF-α, it was necessary to avoid challenging cells 
with an overwhelming amount of TNF-α.  In our in vitro endothelial cell model, the 
binding of TNF-α to its receptor on endothelial cells is followed by rapid translocation of 
the transcription factor NF-κB from the cytoplasm to the nucleus.  This translocation is 
important for stimulated transcription of the adhesion molecules E-selectin, VCAM-1, 
and inducible enzyme COX-2 which all possess NF-κB promoter/enhancer elements.  
Thus, to determine the condition of TNF-α-induced endothelial cell activation, we first 
did time and concentration course studies for E-selectin, VCAM-1, and COX-2.   
Endothelial cells were incubated in the presence of TNF-α concentrations ranging 
from 0.1 to 0.5 ng/ml for 2, 4, or 6 h.  Expression of E-selectin (Fig. 2.1) was assessed by 
RT-PCR.  We observed that as low as 0.2 ng/ml of TNF-α, there was a dramatic increase 
of E-selectin at 4 h.  When endothelial cells were treated with 0.5 ng/ml TNF-α, the 
expression of E-selectin rose within 2 h.  But the increase of E-selectin went back to 
basal level in all the treatment groups after 6 h of incubation.  We confirmed by 
immunofluorescence study that 0.5 ng/ml TNF-α increased cell surface expression of E-
selectin on endothelial cells (Fig. 2.2).  Furthermore, 0.5 ng/ml TNF-α at 4 h also 
increased VCAM-1 and COX-2 (Fig. 2.3) genes expression which were measured by RT-
PCR.  Thus TNF-α at the concentration of 0.5 ng/ml was determined to activate 
endothelial cells in the current study.  
 
Determination of optimal linoleic acid incubation time for endothelial cell activation 
Nutritional habits can result in modified levels of circulating metabolites, 
including free fatty acids. The dietary different fatty acids have been shown to be 
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efficient for modifying inflammatory diseases.  Dietary polyunsaturated free fatty acid 
concentration in plasma has been reported to be 20 -30 μΜ [147] and a concentration 
range of 180-2,5000 μM has also been reported [148].  We next investigated the effect of 
physiological level of linoleic acid (20 μM) alone on endothelial cell activation.  As 
shown in Fig. 2.4, expression of VCAM-1 mRNA rose at 18 h and continuous increasing 
at 24 h.  Thus for inflammatory gene expression study, cells were pretreated with fatty 
acids for 24 h, followed by TNF-α treatment for another 4 h.   
 
Linoleic acid and α-linolenic acid modulate TNF-α-induced E-selectin and COX-2 
expression  
To examine the effects of ω-6 and ω-3 fatty acids on TNF-α-induced endothelial 
activation, cells were pretreated with either linoleic acid or α-linolenic acid for 24 h, 
followed by exposure to TNF-α for another 4 h.  As indicated in Fig. 2.5, 2.6, 
pretreatment with α-linoleic acid significantly decreased TNF-α-induced both E-selectin 
and COX-2 gene expression.  For E-selectin expression, pre-incubation with linoleic acid 
followed by TNF-α didn’t show any different from TNF-α treatment alone (Fig. 2.5).  
But COX-2 mRNA expression was further amplified in the presence of linoleic acid 
compared with TNF-α treatment alone (Fig. 2.6).  We confirmed the COX-2 data by 
measuring protein levels of COX-2 by western blot (Fig. 2.7).  
 
Linoleic acid and α-linolenic acid modulate cellular oxidative stress and NF-κB activity 
induced by TNF-α 
The NF-κB family of transcription factors plays a crucial role in inflammatory 
events induced by TNF-α.  The transcription of adhesion molecules E-selectin, VCAM-1, 
and inducible enzyme COX-2 all possess NF-κB promoter/enhancer elements [149].  
Furthermore, NF-κB is respond directly to oxidative stress [150].  We further assess 
effects fatty acids on TNF-α-induced oxidative stress and NF-κB activation.  Exposure to 
TNF-α alone significantly increased cellular oxidative stress (ROS) (Fig.2.8) and NF-κB 
DNA binding activity (Fig. 2.9).  Pretreatment with linoleic acid following by exposure 
to TNF-α further induced oxidative stress and activation of NF-κB compared to cultures 
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treated only with TNF-α.  In contrast, pretreatment with α-linolenic acid blocked the 
TNF-α-induced both oxidative stress and subsequent induction of NF-κB.   
 
Linoleic acid and α-linolenic acid modulate TNF-α-induced activation of p38 MAPK 
In mammalian cells, MAPKs are strongly activated by growth factors, 
environmental stresses, and inflammatory cytokines [151].  As shown in Fig. 2.10, p38 
MAPK was significantly activated by TNF-α at 10 min and pre-treatment with linoleic 
acid followed by exposure to TNF-α further increased p38 MAPK activation, this event 
was blocked by pre-enrichment with α-linolenic acid.   
In order to further evaluate the role of p38 MAPK in TNF-α-induced 
inflammatory gene expression, endothelial cells were pretreated with the specific p38 
MAPK inhibitor SB203580, followed by exposure to TNF-α for an additional 8 h.  As 
shown in Fig. 2.11 and 2.12, SB203580 significantly decreased TNF-α-induced both 
COX-2 and VCAM-1 protein expression.  These results indicate that p38 MAPK is 
crucially involved in ω-6 and ω-3 fatty acids mediated TNF-α-induced COX-2 
expression.  
 
Induction of cPLA2 phosphorylation by TNF-α 
The biosynthesis of prostaglandin E2 (PGE2), a major lipid-derived inflammatory 
mediator, involves three enzymatic reactions including phospholipase A2 (PLA2), 
cyclooxygenase (COX), and PGE2 synthase.  Cytosolic phospholipase A2 (cPLA2) is the 
most characterized phospholipase members of PLA2 family which are responsible for 
remarkable selectivity toward arachidonic acid at the sn-2 position of phospholipids [152].  
To assess the effect of TNF-α on PGE2 production, we first measured the activation of 
cPLA2.  As shown in Fig. 2.13, TNF-α induced significant increase of cPLA2 
phosphorylation at 8 h treatment.  cPLA2 mRNA expression was not changed after TNF-
α stimulation measured by Real-time PCR.   
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Linoleic acid and α-linolenic acid modulate TNF-α-induced PGE2 production  
We further investigated cellular PGE2 levels after different fatty acids or TNF-α 
treatments.  As shown in Fig. 2.14, an 18 h exposure to linoleic acid dramatically induced 
PGE2 production.  In contrast, α-linolenic acid did not have much induction effect.   
To access the optimal TNF-α incubation time for PGE2 production, cells were 
treated with TNF-α for 6, 18, and 24 h.  As indicated in Fig. 2.15, a 24 h exposure to 
TNF-α significantly induced PGE2 production.  Compared to the TNF-α treatment group, 
enriching endothelial cells with linoleic acid further enhanced TNF-α-induced PGE2 
production.  In contrast, cellular exposure to α-linolenic acid markedly reduced the 
proinflammatory effect of TNF-α (Fig. 2.16). 
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Figure 2.1  Optimal TNF-α concentration and incubation time for E-selectin expression 
 
Cells were treated with indicated concentration of TNF-α for 2, 4, or 6 h.  E-selectin gene 
expression was measured by RT-PCR.  β-actin was used as housekeeping gene. 
 
 
 
Figure 2.2  Immunofluorescence microscopy study of TNF-α-induced E-selectin 
expression  
 
Cells were treated with 0.5 ng/ml TNF-α for 4 h.  Immunofluorescence staining for E-
selectin (FITC green fluorescence) and nuclear (DAPI blue fluorescence) were indicated.  
The merged images were shown to better illustrate the expression of E-selectin for each 
individual cell. 
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Figure 2.3  TNF-α-induced VCAM-1 and COX-2 expression 
 
Cells were exposed to control culture (C), or 0.5 ng/ml TNF-α for 4 h.  VCAM-1 and 
COX-2 gene expression were measured by RT-PCR.  β-actin was used as housekeeping 
gene. 
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Figure 2.4  Optimal linoleic acid incubation time for VCAM-1 gene expression 
 
Cells were incubated with or without 20 μM linoleic acid (LA) for indicated time.  
VCAM-1 gene expression was measured by real-time PCR.  β-actin was used as 
housekeeping gene.  * indicates significant difference from control group without linoleic 
acid. 
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Figure 2.5  Effect of linoleic acid and α-linolenic acid on TNF-α-induced E-selectin gene 
expression 
 
Cells were treated with 0.5 ng/ml TNF-α alone for 4 h, or pretreated with 20 μM 
linoleic acid (LA)/α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 
additional 4 h.  E-selectin gene expression was measured by real-time PCR.  β-actin was 
used as housekeeping gene.  Experiments were repeated three times.  Different letters 
represent significant differences among treatment groups.  Capital or small letters 
represent with or without TNF-α treatment respectively as were compared separately by 
one way ANOVA. 
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Figure 2.6  Effect of linoleic acid and α-linolenic acid on TNF-α-induced COX-2 gene 
expression 
 
Cells were treated with 0.5 ng/ml TNF-α alone for 4 h, or pretreated with 20 μM 
linoleic acid (LA)/α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 
additional 4 h.  COX-2 gene expression was measured by real-time PCR.  β-actin was 
used as housekeeping gene.  Experiments were repeated three times.  Values are means±
SEM.  Different letters represent significant differences among treatment groups.  Capital 
or small letters represent with or without TNF-α treatment respectively as were compared 
separately by one way ANOVA. 
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Figure 2.7  Effect of linoleic acid and α-linolenic acid on TNF-α-induced COX-2 protein 
expression 
 
Cells were pretreated with 20 μM of linoleic acid or α-linolenic acid for 24 h and 
then exposed to 0.5 ng/ml TNF-α for an additional 8 h.  COX-2 protein levels were 
measured by western blot.  β-Actin was used as a housekeeping gene.  Experiments were 
repeated three times, and the blots shown are representative of one of the experiments.  
Values are means ± SEM.  Different letters represent significant difference among 
treatment groups.  
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Figure 2.8  Effect of linoleic acid and α-linolenic acid on TNF-α-induced oxidative stress 
 
Cultures were pretreated in media supplemented with 20 μM linoleic acid (LA) or α-
linolenic acid (ALA) for 24 h followed by exposure to 0.5 ng/ml TNF-α for additional 3 
h.  Values are means ± SEM (n = 3).  Different letters represent significant differences 
among the treatment groups.   
 
 34  
 
 
  
 
 
Figure 2.9  Effect of linoleic acid and α-linolenic acid on TNF-α-induced activation of 
NF-κB 
 
Cells were treated with 20 μM of linoleic acid (LA) or a-linolenic acid (ALA) for 24 h 
prior to exposure to 0.5 ng/ml TNF-α for an additional 6 h.  Experiments were repeated 
three times, and the blots shown are a representative of one of the experiments.  The bar 
graph shows the corresponding densitometric analysis of the blots.  Values are means ± 
SEM.  Different letters represent significant differences among treatment groups.   
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Figure 2.10  Effect of linoleic acid and α-linolenic acid on TNF-α-induced p38 MAPK 
activation 
 
Cells were pretreated with 20 μM of linoleic acid (LA) or a-linolenic acid (ALA) for 24 h 
and then exposed to 0.5 ng/ml TNF-α for 10 min.  Phosphorylated and total p38 MAPK 
were detected by western blot using specific dually phosphorylated p38 MAPK antibody 
(Thr 180/Tyr 182) or anti-total p38 MAPK antibody respectively.  Experiments were 
repeated three times and the blots shown are a representative of one of the experiments.  
Values are means ± SEM.  Different letters represent significant difference among 
treatment groups.   
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Figure 2.11  Effect of p38 MAPK inhibitor on TNF-α-induced COX-2 up-regulation 
 
Cells were exposed to 0.5 ng/ml TNF-α for 8 h, or first pre-enriched with 10 μM 
SB203508 for 30 min followed by co-exposure to TNF-α for additional 8 h.  COX-2 
protein levels were measured by western blot.  β-Actin was used as a housekeeping gene.  
Experiments were repeated three times and the blots shown are a representative of one of 
the experiments.  Different letters represent significant differences among treatment 
groups.   
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Figure 2.12  Effect of p38 MAPK inhibitor on TNF-α- and linoleic acid-induced VCAM-
1 up-regulation 
 
Cells were exposed to 0.5 ng/ml TNF-α for 8 h or linoleic acid (LA) for 24 h, or first pre-
enriched with 10 μM SB203508 for 30 min followed by co-exposure to TNF-α or LA.  
VCAM-1 protein levels were measured by western blot.  β-Actin was used as a 
housekeeping gene.   
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Figure 2.13  Effect of TNF-α on cPLA2 activation 
 
Cells were treated with 0.5 ng/ml TNF-α for 4, 6, or 8 h.  cPLA2 phosphorylation was 
measured by western blot using specific p-cPLA2 antibody.  β-actin was used as 
housekeeping gene.  Experiments were repeated three times.  Values are means±SEM.  
Different letters represent significant difference among treatment groups.  * indicates 
significant difference from other treatment groups. 
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Figure 2.14  Effect of linoleic acid and α-linolenic acid on PGE2 production 
 
Cells were exposed to 20 μM linoleic acid (LA) or α-linolenic acid (ALA) 18 and 24 h.  
Supernatants of cell cultures were collected and PGE2 levels were measured by enzyme 
immunoassay (EIA).  Bars represent means ± SEM from three independent experiments.   
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Figure 2.15  Optimal TNF-α incubation time for PGE2 production 
 
Cells were exposed to 0.5 ng/ml TNF-α for 6, 18 and 24 h.  Supernatants of cell cultures 
were collected and PGE2 levels were measured by enzyme immunoassay (EIA).  Bars 
represent means ± SEM from three independent experiments.  * represents significant 
difference compared with the control treatment.   
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Figure 2.16  Effect of linoleic acid and α-linolenic acid on TNF-α-induced PGE2 
production 
 
Cells were pretreated with 20 μM of LA or ALA for 24 h and then exposed to 0.5 ng/ml 
TNF-α for additional 24 h.  Supernatants of cell cultures were collected and PGE2 levels 
were measured by EIA.  Values are means ± SEM.  Different letters represent significant 
difference among treatment groups. 
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Figure 2.17  Proposed mechanism for fatty acid-mediated modulation of endothelial cell 
activation induced by TNF-α 
 
Omega-6 or omega-3 fatty acids can either enhance or reduce ΤΝF-α-induced p38 
MAPK activation, oxidative stress (ROS), and NF-κB activation.  Relative activation of 
NF-κB will further regulate VCAM-1, as well as COX-2 enzyme activity and subsequent 
PGE2 release from endothelial cells.   
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Discussion 
Atherosclerosis is considered an inflammatory disease, which involves the 
interplay of prooxidative activities, induction of inflammatory cytokine, activation of 
vascular endothelial cells and activation of adhesion molecules, all events which promote 
vascular leukocyte infiltration and plaque development [6].  Inflammatory events also 
include the cyclooxygenase and subsequent eicosanoid pathways [153, 154].  For 
example, inflammatory cytokines like interleukin-1beta (IL-1-β) can induce COX-2 
expression and the release of PGE2, events which may be mediated through activation of 
p42/44 and p38 MAPKs, and the NF-κB pathway [155].  Our data demonstrate the TNF-
α can markedly induce oxidative stress, p38 MAPK, NF-κB, COX-2 and PGE2. 
Sever hypertriglyceridemia has been identified as an independent risk factor for 
atherosclerosis, and increased circulating free fatty acid levels are associated with 
hypertriglyceridemia and obesity [122].  High plasma free fatty acids may contribute to 
an environment of increased oxidative stress and inflammation in the vasculature [123, 
124], and we have previously shown that linoleic acid can markedly amplify a TNF-α-
mediated endothelial inflammatory response [156].  We also have recently demonstrated 
that both the extracellular signal regulated kinase (ERK1/2) and phosphoinositide-3 
kinase/ amino kinase terminal (PI3K/Akt) signaling pathways can contribute to the effect 
of linoleic acid on NF-κB-dependent transcription and endothelial cell activation [105].  
In the current study, exposure to TNF-α induced oxidative stress, p38 MAPK, NF-κB, 
COX-2 and PGE2, which was amplified by pre-enrichment with linoleic acid.  This 
clearly supports our hypothesis that diets high in omega-6 fatty acids, and especially in 
linoleic acid, are proinflammatory and thus may contribute to the early pathology of 
atherosclerosis.   
In contrast to omega-6 fatty acids, epidemiological and interventional studies 
have shown a dose-dependent decrease in risk of cardiovascular disease endpoints with 
increased dietary consumption of moderate amounts of omega-3 fatty acids, either plant 
or marine derived [126].  Our data clearly demonstrate the anti-inflammatory properties 
of omega-3 fatty acids.  In fact, our observed TNF-α induced oxidative stress, p38 
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MAPK, NF-κB, COX-2 and PGE2 in endothelial cells was blocked or reduced when cells 
were enriched relatively more with α-linolenic acid than with linoleic acid.  Mechanisms 
of vascular inflammation are largely regulated through p38 MAPK signaling [157-160], 
and our data suggest that p38 MAPK is an important player in different ω-6 and ω-3 fatty 
acid modified TNF-α-induced inflammatory signaling cascade.  The p38 MAPK inhibitor 
SB203580 significantly decreased TNF-α-mediated induction of COX-2 protein 
expression, suggesting a regulatory aspect through p38 MAPK signaling.  This was 
supported by the evidence that p38 MAPK increases NF-κB recruitment in cells exposed 
to inflammatory stimuli [161].  
Reactive oxygen intermediates have been reported to function as second 
messengers in the activation of intracellular signaling cascades, particularly the activation 
of the transcription factors NF-κB and AP-1 [162].  The MAPK signaling cascades are 
involved in the regulation and activation of these transcription factors [105].  Superoxide 
dismutase (SOD) has been shown to inhibit TNF-α-induced activation of p38 MAPK, 
NF-kB, and AP-1, thus reduces expression of VCAM-1 and ICAM-1 [144].  Implied that 
antioxidants have beneficial effect in pathological events involving leukocyte adhesion.   
Components of the MAPK pathway have been implicated as mediators of 
phosphorylation of intracellular substrates such as protein kinases and transcription 
factors.  In mammalian cells, at least three different subfamilies of MAPK have been 
identified: extracellular signal-regulated kinases (ERKs) with isoforms p44 MAPK 
(ERK1) and p42 MAPK (ERK2); stress-activated protein kinases also called c-Jun N-
terminal kinases (JNKs), and the p38 MAPKs.  It has been demonstrated that both JNK 
and p38 MAPK cascades are activated preferentially by the inflammatory cytokines such 
as TNF-α, as well as by a wide variety of cellular stresses such as ultraviolet light, heat 
shock, oxidative stress, etc. [163, 164].  Whereas activation of ERK group of MAPK is 
not currently considered a general event associated with TNF-α stimulation and is 
actually primarily involved in control of growth and differentiation [165, 166].  In 
general, the ERKs are mostly activated by mitogenic and proliferative stimli, whereas the 
JNKs and p38 MAPKs respond to environmental stress, including inflammatory 
cytokines [160].  Inhibition of the p38 MAPK is considered to be a promising candidate 
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for treatment of chronic inflammation [167].  p38 MAPK plays an important role in the 
regulation of NF-κB recruitment to a subset of genes activated in cells exposed to 
inflammatory stimuli, and a proposed mechanism is that p38 MAPK can modulate the 
accessibility of selected NF-κB sites in the genome [161].  P38 MAPK pathway has also 
been shown to involve in the induction of several other inflammatory molecules, such as 
COX-2, implicated in the regulation of inflammatory mediators, including PGE2 [167].  
P38 MAPK has been shown to involve in TNF-α-stimulated NF-κB activation and 
interleukin-6 expression [168].  Our data showed that pharmacologic inhibition of p38 
MAPK by SB203508 inhibited TNF-α-induced stimulation of VCAM-1, COX-2 and 
subsequently PGE2 synthesis.  Furthermore, MAPK signaling appears to be involved in 
regulating omega-6 fatty acid and TNF-α-induced endothelial cell activation and 
modification by omega-3 fatty acids (Fig. 2.8).   
Thus, data from the current study provide evidence that an increase in dietary 
omega-3 fatty acids contributes to an anti-inflammatory environment, which may involve 
cellular signaling through local repletion of selected eicosanoid species.  
 
 
 
Copyright © Lei Wang 2007 
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Chapter Three : Involvement of Caveolae in Regulation of Endothelial Cell 
Activation Mediated by Fatty Acids and TNF-α 
Synopsis 
TNF-α transduces inflammatory responses through its receptor TNF receptor-1 
(TNFR-1) which has been indicated to be enriched in plasma membrane microdomains 
caveolae.  Hypertriglyceridemia and associated high circulating free fatty acids are 
important risk factors of atherosclerosis.  In contrast to omega-3 fatty acids, linoleic acid, 
the major omega-6 unsaturated fatty acid in the American diet, may be atherogenic by 
amplifying an endothelial inflammatory response.  We hypothesize that omega-6 and 
omega-3 fatty acids can differentially modulate TNF-α-induced endothelial cell 
activation and that functional called caveolae are required for endothelial cell activation.  
Caveolae are particularly abundant in endothelial cells and play a major role in 
endothelial trafficking and the regulation of signaling pathways associated with the 
pathology of vascular diseases.  To test our hypothesis, endothelial cells were pre-
enriched with either linoleic acid or α-linolenic acid prior to TNF-α-induced endothelial 
activation.  Measurements included oxidative stress and NF-κB-dependent induction of 
COX-2 and PGE2 under experimental conditions with intact caveolae and with cells in 
which caveolin-1 was silenced by siRNA.  Image overlay demonstrated TNF-α-induced 
co-localization of TNF receptor type 1 (TNFR-1) with caveolin-1.  Caveolin-1 was 
significantly induced by TNF-α, which was further amplified by linoleic acid and 
blocked by α-linolenic acid.  Furthermore, silencing of the caveolin-1 gene completely 
blocked TNF-α-induced production of COX-2 and PGE2 and significantly reduced the 
amplified response of linoleic acid plus TNF-α.  These data suggest that omega-6 and 
omega-3 fatty acids can differentially modulate TNF-α-induced inflammatory stimuli and 
that caveolae and its fatty acid composition play a regulatory role during TNF-α-induced 
endothelial cell activation and inflammation. 
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Introduction 
TNF-α exerts its cellular and pathological effects by binding to TNF receptor 
(TNFR).  There are two distinct subtypes of TNFR: TNFR1 and TNFR2 [169].  TNF 
receptors themselves have no metabolic capability and must bind intracellular proteins to 
control the signaling of its target cell’s biochemistry.   
Dietary ω-3 fatty acids have been shown to markedly alter the lipid composition 
of colonic caveolae/lipid rafts in mice fed with fish oil, relative to mice fed with ω-6 fatty 
acids [73].  Caveolae are 50- to 100-nm cell-surface plasma membrane invaginations that 
are particularly abundant in endothelial cells, where they are believed to play a major role 
in the regulation of endothelial vesicular trafficking and signal transduction.  Caveolin-1-
deficient mice suggested an important role for caveolin-1 in the pathogenesis of 
atherosclerosis, and vascular disease [170].   
Furthermore, TNF signaling is initiated at the plasma membrane which is not 
homogenous.  Recent evidence indicates that TNFR1 is enriched in caveolae [79] and it 
can form complex with caveolin-1 [171].  Caveolae are flask-shaped invaginations of 
plasma membrane which are composed of caveolin-1, -2 and cholesterol and 
glycosphingolipids.  These organelles were originally discovered in the early 1950s in 
bladder epithelium [172], and have since been observed in adipocytes, fibroblasts, 
smooth and striated muscle cells, and endothelial cells show the greatest abundance [54].  
Caveolae have been well accepted to function as signaling platforms.  Caveolin-1 is the 
structural protein for caveolae which are the functional lipid rafts organelles abundant in 
endothelial cells.  Recently, it has been more accepted that caveolae can also play a key 
role in cell signaling, because caveolae especially caveolin-1 has been shown to interact 
with many types of plasma membrane receptor proteins and concentrate these molecules 
with the caveolae [51].   
There is evidence that fatty acids can alter localization and function of caveolae-
associated signaling proteins in mouse colonic mucosa [73].  Besides their role in cellular 
uptake of lipophilic substances, including fatty acids [173], caveolae house an array of 
cell signaling molecules, and numerous genes involved in endothelial cell dysfunction 
and inflammation are associated with caveolae [170].  Examples of caveolae facilitated 
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targeting of proteins involved in pro-inflammatory signal transduction include activators 
of p44/p42 (ERK) MAPK pathway, H-Ras [76, 174], non-receptor tyrosine kinase c-Src 
[174], and the upstream regulator of NF-κB, IKK [175].  Furthermore, caveolins have 
been reported to co-localize with cyclooxygenase, suggesting that caveolins play a role in 
regulating the function of this enzyme [176, 177].   
A major objective of the current study was to explore specific mechanisms 
involved in fatty acid-mediated activation of endothelial cells.  Our current data support 
our hypothesis that omega-6 and omega-3 fatty acids can differentially modulate TNF-α-
induced endothelial cell activation and that regulatory mechanisms are associated within 
caveolae and linked to caveolae function and associated gene inductions. 
 
Materials and Methods  
Measurement of caveolin-1 protein level by western blot 
Cells were harvested using cell lysis buffer as previously described [105].  15 μg 
protein samples were resolved by SDS-PAGE using 15% gradient gels and transferred 
electrophoretically to nitrocellulose membranes using a Bio-Rad immunoblot transfer 
apparatus (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s 
instructions.  The nonspecific sites on the membrane were blocked 1 h at room 
temperature with 5% nonfat dry milk in TBST followed by incubation with caveolin-1 
primary antibody at a dilution of 1:20,000 overnight at 4 °C.  Caveolin-1 primary 
antibody was diluted 10 times from the original before using filtered PBS.  β-actin was 
used as a house keeping gene.  Bands were visualized using the appropriate horseradish 
peroxidase-conjugated secondary antibodies followed by ECL immunoblotting detection 
reagents (Amersham Biosci, UK).  Hyperfilm (Amersham) was used for the visualization.  
Detection and quantitative analysis of the density of the bands were performed using a 
digitizing system (UN-SCAN-IT, Silk Scientific Corporation).  To determine the optimal 
amounts of samples for linear area detection, a titration of different amounts of sample 
were loaded.  For caveolin-1, 15 μg protein were loaded and for COX-2, 30 μg protein 
were loaded. 
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Immunofluorescence microscopy 
This technique was adapted from previous protocols [178].  Cells were plated on 
LAB-TEKII chamber slides (Nalge Nunc International, Naperville, IL) and grown to 
confluence.  After experimental treatments, cells were fixed in 4% (vol/vol) 
paraformaldehyde (in PBS) for 1 h at room temperature.  After permeabilization with 
0.1% (vol/vol) Triton X-100 in PBS for 5 min, cells were washed three times with PBS.  
Nonspecific binding sites were blocked with 5% (vol/vol) donkey serum in PBS.  Cells 
were then incubated with anti-caveolin-1 antibody (Affinity BioReagents, Golden, CO) 
and anti-TNFR-1 antibody (R&D Systems, Minneapolis, MN), followed by incubation 
with Alexa Fluor 488-labeled donkey anti-mouse IgG antibody and Alexa Fluor 546-
labeled donkey anti-goat IgG antibody respectively (Invitrogen-Molecular Probes, 
Carlsbad, CA).  Cell nuclei were stained using Hoechst (AnaSpec Inc., San Jose, CA).  
Slides were mounted in Aqueous Mounting Medium with Anti-fading Agents (Biomeda 
Corp., Foster City, CA) and covered with coverslips.  Images were captured digitally by 
Fluoview 300 Confocal Microscopy (Olympus America Inc., PA).  In order to avoid 
artificial effects, the detection of the control group was set at a lower level than in Fig. 
3.2.  For all the other three treatment groups the strength of individual lasers, the level of 
contrast, and brightness were kept at the same condition as used for the control group. 
 
Sucrose density gradient fraction of caveolin-1 protein 
Three 100 mm culture dishes were used for each treatment group.  Sucrose 
gradient ultracentrifugation was utilized as described in Appendix B.  In brief, the 
sucrose gradient was created by gently overlaying lower concentrations of sucrose on 
higher concentrations in a centrifuge tube.  Cells were washed twice with PBS and lysed 
with ice-cold MES-buffered saline.  Sucrose was added to the lysate (final concentration 
of sucrose 45%), and the lysate was placed at the bottom of the ultracentrifuge tube and 
overlaid with lysis buffer containing 35 and 5% sucrose, respectively.  After 
centrifugation at 39,000 rpm for 16 h, different particles travel through the gradient until 
they reach the point in the gradient at which their density matches that of the surrounding 
sucrose.  Twelve 1 ml fractions from the top to the bottom were collected.  Each fraction 
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was analyzed by Western blot for its caveolin-1 contents using specific caveolin-1 
antibody.   
 
Detergent-free caveolae membrane purification 
Ten 100 mm culture dishes were combined for each treatment group.  Detergent-
free caveolae membrane purification was followed Dr. Smart’s method [179] with minor 
adjustment.  This procedure generates a highly purified plasma membrane microdomain 
that is free from intracellular markers and bulk plasma membrane markers and has ben 
used extensively to characterize caveolae membrane signaling events [180, 181].  After 
multiple ultracentrifugations with 5 to 15% OptiPrep gradient, the band at the 5% 
interface was collected and designated caveolae membranes.  The cytosol fraction is 
obtained by collecting the overlaid material on the Percoll gradient, centrifuging again, 
and collecting the resulting supernatant.  The plasma membranes are obtained by pooling 
the bottoms of both OptiPrep gradients.  Each fraction was analyzed by Western blot for 
its caveolin-1 contents using specific caveolin-1 antibody.  1 ng protein was loaded for 
each sample.  
 
Caveolin-1 siRNA design and transfection 
Caveolin-1 gene silencing was adapted from Salani et al [182, 183].  The silence 
of caveolin-1 gene (GenBank Accession No. NM001753) was performed using a mix of 
two siRNAs directed against the following two target sequences: 5’-
AACAGGGCAACATCTACAAGC-3’ and 5’-AACCAGAAGGGACACACAGTT-3’.  
The sequence of control siRNA was as followed: 5’-AAAGAGCGACTTTACACACTT-
3’.  Cells were grown in 60 mm plates until 100% confluent and transfected with control 
siRNA or caveolin-1 siRNA at a final concentration of 40 nM using GeneSilencer 
(Genlantis, San Diego, CA) in Optimem I medium (Invitrogen, Carlsbad, California).  
Cells were incubated with 1 ml/plate serum free transfection mixtures for 4 hr, and then 
add 1 ml/plate of 20% FBS OptiMEM to achieve the final concentration of 10% FBS in 
the medium.  48 h after transfection, replace the medium by 5% FBS M199 overnight and 
then treated with TNF-α in the presence or absence of linoleic acid. 
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PGE2 determination 
Cells were seeded in 60 mm culture dishes (Becton Dickinson Labware, NJ) and 
grown to confluence.  After transfected with caveolin-1 siRNA or control siRNA, cells 
were pretreated with linoleic acid followed by TNF-α exposure.  After treatment, 
supernatants of cell cultures were collected into microcentrifuge tubes (Isc BioExpress, 
UT), centrifuged at 4 °C to remove cellular debris and stored at -80 °C.  PGE2 levels were 
assessed using a PGE2-specific enzyme immunoassay (EIA) (Cayman Chemicals, MI) 
following the manufacturer’s protocol.  Absorbance at 405 nm was detected using a 
microplate spectrophotometer SpectraMaxPro M2 (Molecular Devices Corporation, CA). 
 
Statistical analysis 
Values are reported as mean ± standard error of the mean (SEM) of at least three 
independent experiments.  Data were analyzed using Sigma Stat software (Jandel Corp., 
Wan Rafael, CA).  One way ANOVA was followed by post hoc comparisons using the 
least significant difference (LSD) method.  A statistical probability of p< 0.05 was 
considered significant.  Different letters represent significant differences among treatment 
groups.  Capital or small letters represent caveolin-1 silencing or control silencing 
respectively as were compared separately by one way ANOVA. 
 
 
Results  
Fatty acids and TNF-α modulated caveolin-1 expression 
There is increasing evidence that lipid raft proteins and lipids play an important 
role in health and disease [184].  A major subclass of lipid rafts are caveolae, i.e., 
membrane domains which have been implicated in the pathology of atherosclerosis [170].  
The lack of the caveolin-1 gene may provide protection against the development of 
atherosclerosis [185].  This may be important in understanding mechanisms of 
atherosclerosis, because caveolae are particularly abundant in endothelial cells, where 
they are believed to play a major role in the regulation of endothelial vesicular trafficking 
as well as the uptake of lipids and related lipophilic compounds [186].  To assess the 
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effects of linoleic acid and α-linolenic acid on caveolin-1 expression, endothelial cells 
were incubated with either linoleic acid or α-linolenic acid for 24 h.  As indicated in Fig. 
3.1, caveolin-1 protein level was significantly down-regulated by α-linolenic acid 
compared with the control culture, while there was no different in the linoleic acid 
treatment from control group.  We next investigated the effect of TNF-α on caveolin-1 
expression.  As shown in Fig. 3.2, TNF-α increased caveolin-1 expression at 4 h 
measured by immunofluorescence study.  We can also observe the basal level of 
caveolin-1 expression in the control culture.  
 
Linoleic acid and α-linolenic acid modulate TNF-α-induced caveolin-1 up-regulation 
and the co-localization of TNFR-1and caveolin-1 
The first step in the TNF-α-induced inflammatory response is the binding of the 
cytokine to its cognate receptor.  TNF receptor type 1 (TNFR-1) has been reported to be 
enriched in caveolae [79].  Caveolin-1 has also been shown to form a complex with the 
TNF receptor [171].  We further pre-incubated endothelial cells with either linoleic acid 
or α-linolenic acid, followed by activation with TNF-α.  The immunofluorescence 
images in Fig. 3.3 demonstrated that TNF-α can increase caveolin-1 and TNFR-1 
expression compared with the control group, and that pretreated cells with linoleic acid 
followed by TNF-α can further increase these effects compared with TNF-α treatment 
alone.  Cells pretreated with α-linolenic acid followed by exposure to TNF-α diminished 
TNF-α-induced both caveolin-1 and TNFR-1 up-regulation.  Similar effects of linoleic 
acid and α-linolenic acid on TNF-α-induced caveolin-1 expression were observed by 
measuring caveolin-1 protein levels by western blot (Fig. 3.4).  
 
Linoleic acid and α-linolenic acid modulate TNF-α-induced caveolin-1 re-distribution 
To further establish the caveolar localization of TNFR-1, after treated cells with 
different fatty acids for 24 h followed by 4 h TNF-α treatment, we used sucrose density 
gradient centrifugation.  12 fractions were collected and transferred to nitrocellulose 
membrane by Western blot.  Caveolin-1 protein levels were analyzed by caveolin-1 
specific antibody.  As indicated in Fig. 3.5, in the control culture, caveolin-1 protein were 
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most enriched in fraction 4 and 5 (containing 5% sucrose, represent detergent-resistant 
membranes).  TNF-α induced a shift of caveolin-1 protein into fraction 3 and linoleic 
acid further amplified this effect.  In contrast, α-linolenic acid diminished TNF-α-
induced the shift of caveolin-1 into fraction 3, and even decreased caveolin-1 in fraction 
5 compared with control treatment.  To confirm that the observation of this shift was not 
due to uneven transfer or other artificial effects, we analyzed fractions 3, 4, and 5 from all 
the four treatment groups on one western blot gel and similar results were observed (Fig. 
3.5, lower panel).  In fractions 7 to 9, we also observed a shift of caveolin-1 protein from 
fraction 8 and 9 into fraction 7 after TNF-α treatment.  In the presence of linoleic acid, 
the TNF-α-induced shift into fraction 7 was amplified.  But in the presence of α-linolenic 
acid, there was no change of the TNF-α-induced shift compared with TNF-α treatment 
alone.  In fractions 10 to 12 (containing 45% sucrose) we didn’t observe the association 
of caveolin-1 protein.   
Furthermore, the results of detergent-free caveolae membrane purification 
indicated that only in the presence of linoleic acid, caveolin-1 was enriched in cytosol 
membrane proportion (Fig. 3.6).  These date suggested that linoleic acid or α-linolenic 
acid had profound modulation effects on caveolin-1 distribution.   
 
Caveolin-1 silencing decreases TNF-a-induced caveolin-1 and COX-2 expression, 
subsequently diminishes PGE2 production  
In order to determine the role of caveolin-1 in fatty acids-modulated TNF-α-
induced endothelial cell activation, we utilized small interfering RNA (siRNA) to 
specifically down-regulate caveolin-1.  As indicated in Fig. 3.7, after 48 h transfection of 
caveolin-1 siRNA or control siRNA, cells were exposed to TNF-α for 4 h, in both control 
and TNF-α treatment groups, caveolin-1 siRNA specifically reduced caveolin-1 protein 
expression by approximately 80%.  Similar decreasing effect by siRNA was also 
observed after 24 h treatment with TNF-α in the presence or absence of linoleic acid (Fig. 
3.8).  TNF-α-induced COX-2 expression was totally blocked by caveolin-1 silencing (Fig. 
3.9) and caveolin-1 silencing also diminished the combined COX-2 induction induced by 
both linoleic acid and TNF-α.  Similar to the COX-2 data, caveolin-1 silencing blocked 
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TNF-α-induced PGE2 production and also diminished TNF-α-induced PGE2 production 
in the presence of linoleic acid (Fig. 3.10).  The effect of linoleic acid-induced COX-2 
expression and PGE2 production were not changed after caveolin-1 silencing.  Clearly, 
the functional caveolae are important for TNF-α-induced up-regulation of COX-2 and 
subsequently production of PGE2.  Linoleic acid-induced COX-2 expression and PGE2 
production were not caveolae dependent, indicated that an alternative signaling pathway 
might be involved.   
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Figure 3.1  Effect of linoleic acid and α-linolenic acid on caveolin-1 expression 
 
Cells were treated with 20 μM of linoleic acid (LA) or α-linolenic acid (ALA) for 24 h.  
Experiments were repeated three times, and the blots shown are a representative of one of 
the experiments.  The bar graph shows the corresponding densitometric analysis of the 
blots.  Values are means ± SEM.  Different letters represent significant differences 
among treatment groups.   
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Figure 3.2  Immunofluorescence microscopy study of TNF-α-induced caveolin-1 up-
reguation. 
 
Cells were treated with 0.5 ng/ml TNF-α for 4 h.  FITC green fluorescence was used for 
immunofluorescence staining of caveolin-1.  Experiment were repeated three times and 
the epifluorescence micrographs shown are representative fields of one of the 
experiments (original magnification, X 400).   
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Figure 3.3  Effect of linoleic acid and α-linolenic acid on TNF-α-induced TNFR-1 and 
caveolin-1 localization 
 
Cells were treated with 0.5ng/ml TNF-α alone for 4 h, or pretreated with 20 μM linloleic 
acid (LA) or α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 4 h.  
Immunofluorescence staining for caveolin-1 (FITC green fluorescence), TNF Receptor-1 
(TNFR-1) (Texas red fluorescence), and nuclear (DAPI blue fluorescence).  The merged 
images were shown to better illustrate the partial colocalization between caveolin-1 and 
TNFR-1 in the same cells.  Experiments were repeated three times and the 
epifluorescence micrographs shown are representative fields of one of the experiments 
(original magnification, X 400).   
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Figure 3.4  Effect of linoleic acid and α-linolenic acid on TNF-α-induced caveolin-1 
expression 
 
Cells were treated with 0.5ng/ml TNF-α alone for 4 h, or pretreated with 20μM linoleic 
acid (LA) or α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 4 h.  
Caveolin-1 protein levels were detected by western blot.  β-Actin was used as a 
housekeeping gene in the measurement.  Experiments were repeated three times, and the 
blots shown are a representative of one of the experiments.  The bar graph shows the 
corresponding densitometric analysis of the blots.  Values are means ± SEM.  Different 
letters represent significant differences among treatment groups. 
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Figure 3.5  Effects of fatty acids on TNF-α-induced caveolin-1 redistribution 
 
Cells were treated with 0.5ng/ml TNF-α alone for 4 h, or pretreated with 20 μM linoleic 
acid (LA) or α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 4 h.  
Caveolin-1 distribution was measured by glucose sucrose gradient.  Fractions 1 to 3 
containing 5% sucrose, fractions 4 to 8 containing 35% sucrose, fractions 9 to 12 
containing 45% sucrose.   
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Figure 3.6  Effects of fatty acids on TNF-α-induced caveolin-1 redistribution 
 
Cells were treated with 0.5ng/ml TNF-α alone for 4 h, or pretreated with 20 μM linoleic 
acid (LA) or α-linolenic acid (ALA) for 24 h followed by exposure to TNF-α for 4 h.   
Different cellular membranes were isolated using detergent-free caveolae membrane 
purification.  This method has been well established, and different isolated membranes 
have been confirmed by specific markers.  
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Figure 3.7  Effect of caveolin-1 silencing on TNF-α-induced caveolin-1 up-regulation 
 
Cells were first transfected with siRNA for caveolin-1 (Cav-1 siRNA) or with scrambled 
control siRNA for 48 h.  Then cells were treated with 0.5ng/ml TNF-α for 4 h.  Whole 
cell lysate was collected and caveolin-1 protein levels were measured by western blot. 
 
 
 
Figure 3.8  Effect of caveolin-1 silencing on linoleic acid and TNF-α-induced caveolin-1 
expression 
 
Cells were first transfected with siRNA for caveolin-1 (Cav-1 siRNA) or with scrambled 
control siRNA, then treated with 0.5ng/ml TNF-α or linoleic acid (LA) alone for 24 h, or 
pretreated with 20μM LA for 24 h followed by exposure to TNF-α for additional 24 h.  
Whole cell lysate was collected and caveolin-1 protein levels were measured by western 
blot.  β-Actin was used as a housekeeping gene.  Experiments were repeated three times 
and the blots shown are a representative of one of the experiments. 
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Figure 3.9  Effect of caveolin-1 silencing on linoleic acid and TNF-α-induced COX-2 
expression 
 
Cells were first transfected with siRNA for caveolin-1 (Cav-1 siRNA) or with 
scrambled control siRNA.  Then cells were treated with 0.5ng/ml TNF-α alone for 24 h, 
or pretreated with 20μM LA for 24 h followed by exposure to TNF-α for additional 24 h.  
COX-2 protein levels were measured by western blot under the same experimental 
conditions as in Fig. 3.5B.  β-Actin was used as a housekeeping gene.  Experiments were 
repeated three times, and the blots shown are representative of one of the experiments.  
Values are means ± SEM.  Different letters represent significant difference among 
treatment groups.  Capital or small letters represent caveolin-1 silencing or control 
silencing respectively as were compared separately by one way ANOVA. 
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Figure 3.10  Effect of caveolin-1 silencing on linoleic acid and TNF-α-induced PGE2 
production 
 
Cells were first transfected with siRNA for caveolin-1 (Cav-1 siRNA) or with 
scrambled control siRNA.  Then cells were treated with 0.5ng/ml TNF-α or linoleic acid 
(LA) alone for 24 h, or pretreated with 20μM LA for 24 h followed by exposure to TNF-
α for additional 24 h.  Supernatants of cell cultures were collected and PGE2 levels were 
measured by EIA under the same experimental conditions as in Fig. 3.8 and 3.9.  
Experiments were repeated three times and the blots shown are a representative of one of 
the experiments.  Values are means ± SEM.  Different letters represent significant 
differences among treatment groups.  Capital or small letters represent caveolin-1 
silencing or control silencing respectively as were compared separately by one way 
ANOVA. 
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Discussion  
Caveolae, specific microdomains of the plasma membrane, can concentrate 
different membrane receptors, signaling molecules and membrane transporters to vary 
extents.  Caveolins are thought to function as scaffolding proteins that organize and 
concentrate cholesterol, glycosphingolipids and lipid-modified signaling molecules, such 
as endothelial nitric oxide synthase, H-ras, Src-like kinases, G protein and several 
hormone receptors within caveolae [187, 188].  The binding of both free cholesterol and 
protein by caveolae involves the same, short sequence in caveolin (residues 61 to 101) 
[187].  This implies that there might be a competition between lipids and proteins for the 
same site, within a highly ordered assembly of multiple caveolin molecules within a 
single caveola, in which individual polypeptides have assigned roles in the binding of 
either free cholesterol or protein.  Several proteins of cellular lipid homeostasis are found 
in caveolae, including annexin II, lipoprotein scavenger receptors and CD36 [189].  
These proteins do not have a caveolin-binding scaffold consensus sequence, suggesting 
that their primary interaction is with the lipid, not protein, moiety of caveolae [190].   
Our data presented in Chapter 2 suggest that exposure to TNF-α can cause 
endothelial cell activation and that fatty acids (and in particular linoleic acid) can amplify 
TNF-α-induced endothelial activation [156], mechanisms of this interaction may be 
multi-layered and are not known.  We further hypothesized that caveolae play a critical 
role in facilitating the cellular uptake and trafficking of fatty acids and trigger the initial 
cell signaling induced by TNF-α and lipids.  We utilized siRNA-induced down-
regulation of caveolin-1 which is an effective experimental approach to determine the 
role of caveolae in cellular signal transduction.  Our data suggest that functional caveolae 
are necessary for TNF-α-mediated activation of endothelial cells.  TNF-α markedly 
induced both caveolin-1 and TNFR-1, and both expressions were further induced when 
cells were first enriched with linoleic acid.  Furthermore, silencing caveolin-1 totally 
blocked both TNF-α-induced COX-2 expression and cellular release of PCE2.  In human 
foreskin fibroblasts, a significant proportion of induced COX-2 was present in DRM 
fractions concomitantly with caveolin-1 [80].   
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It is very likely that selected fatty acids either stabilize or perturb caveolae 
functions, thus leading to modifications of caveolae-dependent signaling.  There is 
evidence that fatty acids can alter localization and function of caveolae-associated 
signaling proteins in mouse colonic mucosa [73].  Our data suggest that omega-3 fatty 
acids may in part be anti-inflammatory by decreasing caveolin-1 expression or by causing 
dysfunctional caveolae, leading to down-regulation of caveolin-dependent down-stream 
signaling.  Using human breast cancer cells, others have shown recently that omega-3 
fatty acids can alter lipid raft composition and a decrease in epidermal growth factors 
[74], suggesting that selected fatty acids can modify caveolae-associated cell functions.  
There is evidence that caveolae play a role in lipid trafficking and uptake and transport of 
fatty acids [184].  Furthermore, preferential uptake of fatty acids via the FAT/CD36, a 
receptor exclusively located in lipid rafts such as caveolae in the plasma membrane, may 
explain the fatty acid effects we observed.  In fact, working with mouse embryonic 
fibroblasts, it was recently demonstrated that mistargeting of FAT/CD36 in these cells 
lacking the caveolin-1 gene resulted in reduced fatty acid uptake compared with the wild-
type cells [191].  Long-chain omega-3 fatty acids, such as DHA, have been shown to 
induce caveolar cholesterol reduction, this might due to the poor incorporation of 
cholesterol into phospholipids bilayers be explained by in a highly unsaturated lipid 
environment, [192].  In addition, α-linolenic acid has also been shown to modulate 
cholesterol partitioning into model membranes [193].   
Our observations that linoleic acid can amplify the TNF-α-mediated induction of 
both caveolin-1 and COX-2 is significant because of the link between caveolins (caveolae) 
and the pathology of atherosclerosis [170].  Caveolin-1 has been reported to co-localize 
with interleukin-1beta-induced COX-2 [194], suggesting the dependence of COX-2 
induction on functional caveolae.  Recent evidence suggests that high-fat diets can up-
regulate caveolin-1 expression in aorta of diet-induced obese rats [195], suggesting that 
our fatty acid data may mimic an in vivo response by activating COX-2.  High-fat diets 
contribute to hypertriglyceridemia, and the vascular endothelium can be exposed to 
significant levels of free fatty acids derived from lipoprotein lipase-mediated hydrolysis 
of triglyceride-rich lipoproteins [128].   
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In summary, we provide novel data demonstrating that omega-6 and omega-3 
fatty acids can differentially modulate TNF-α-induced inflammatory stimuli and that 
these events require functional caveolae.  Furthermore, functional changes of caveolae 
associated with modifications by dietary fatty acids appear to affect critical phases of 
induction of oxidative stress-sensitive transcription factors and inducible inflammatory 
parameters during endothelial cell activation.  Because caveolae and caveolins have been 
implicated in several human diseases and in particular vascular diseases, our data may 
have implications in understanding novel mechanisms of inflammatory diseases 
modulated by dietary lipids. 
 
Copyright © Lei Wang 2007 
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Chapter Four : Changing Ratios of ω-6 to ω-3 Fatty Acids Can Differentially 
Modulate Polychlorinated Biphenyl Toxicity in Endothelial Cells 
Synopsis  
Exposure to persistent organic pollutants, such as polychlorinated biphenyls 
(PCBs) can cause endothelial cell activation by inducing pro-inflammatory signaling 
pathways.  Our previous studies indicated that linoleic acid (LA, 18:2), a major omega-6 
unsaturated fatty acid in the American diet, can potentiate PCB77-mediated inflammatory 
responses in ECs.  In addition, omega-3 fatty acids (such as α-linolenic acid, ALA, 18:3) 
are known for their anti-inflammatory properties.  We tested the hypothesis that 
mechanisms of PCB-induced endothelial cell activation and inflammation can be 
modified by different ratios of omega-6 to omega-3 fatty acids.  Porcine pulmonary 
arterial endothelial cells were pretreated with linoleic acid, α-linolenic acid, or different 
ratios of these fatty acids, followed by exposure to PCB77.  PCB77-induced oxidative 
stress and activation of the oxidative stress sensitive transcription factor nuclear factor κB 
were markedly increased in the presence of linoleic acid and diminished by increasing the 
relative amount of α-linolenic acid to linoleic acid.  Similar protective effects by 
increasing α-linolenic acid were observed by measuring NF-κB-responsive genes, such 
as vascular cell adhesion molecule-1 (VCAM-1) and cyclooxygenase-2 (COX-2).  COX-
2 catalyzes the rate limiting step of the biosynthesis of prostaglandin E2 (PGE2).  PCB77 
exposure also increased PGE2 levels, which were down-regulated with relative increasing 
amounts of α-linolenic acid to linoleic acid.  Inhibitor studies suggest that NF-κB is a 
critical player in the regulation of PCB-induced inflammatory markers as modulated by 
omega-6 and omega-3 fatty acids.   
 
Introduction  
Substantial evidence from epidemiological studies suggests that cardiovascular 
diseases are linked to environmental pollution.  For example, there was a significant 
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increase in mortality from cardiovascular diseases among Swedish capacitor 
manufacturing workers exposed to polychlorinated biphenyls (PCBs) for at least five 
years [8], and most excess deaths were due to cardiovascular disease in power workers 
exposed to phenoxy herbicides and PCBs in waste transformer oil [9].  Furthermore, an 
increase in hospitalization rates was reported for coronary heart disease in populations 
residing near areas contaminated with persistent organic pollutants [196].  A recent study 
still found excessive concentrations of PCBs in the serum of Yusho victims, 35 years 
after accidental poisoning with PCBs in Nagasaki, Japan [197].  Interestingly, lipid 
peroxidation was markedly enhanced in these victims as well.  These studies suggest that 
populations near contaminated sites are at increased risk to develop cardiovascular 
diseases, and in particular in the presence of additional risk factors, such as 
hypertriglyceridemia and an associated persistent state of oxidative stress.  There is 
evidence linking the aryl hydrocarbon receptor (AhR) with mechanisms associated with 
cardiovascular diseases [198] and that AhR ligands may be atherogenic by disrupting the 
functions of endothelial cells in blood vessels. 
A growing body of literature demonstrated that dietary components can modulate 
the inflammatory response in humans, thereby affecting cardiovascular risk. Evidence 
suggests that nutrition can influcence the lipid milieu, oxidative stress and antioxidant 
status within cells, and thus modulate mechanisms of cytotoxicity mediated by 
environmental pollutants [199].  For example, certain dietary fats may increase the risk to 
environmental insult induced by PCBs, while fruits and vegetables, rich in antioxidant 
and anti-inflammatory nutrients or bioactive compounds, may provide protection [200]. 
Specific fatty acids rich in plant oils, such as linoleic acid (the parent omega-6 
fatty acid), can amplify PCB toxicity in vascular endothelial cells [106].  There is also 
evidence that elevated levels of linoleic acid may enhance the cellular availability of 
PCBs [201].  The average American diet comprises of an excess of ω-6 fatty acids 
compared with ω-3 fatty acids, the ratio can reach 10 to 20:1, and it has been suggested 
that this imbalance could potentially promote a prothrombotic state [202].  Furthermore, 
coplanar PCBs can suppress delta 5 and 6 desaturase activities, thus disrupting the 
synthesis of fatty acid precursors for eicosanoid metabolism [203].  Our own data from 
plasma and livers of LDL receptor-deficient mice support the hypothesis that treatment 
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with PCBs can facilitate clearance of linoleic acid from plasma into vascular tissues [108].  
Such a change in lipid milieu could exacerbate fatty acid- and/or PCB-induced oxidative 
stress and a vascular inflammatory response.   
In contrast to omega-6 fatty acids, omega-3 fatty acids can influence 
cardiovascular disease pathology by beneficially modulating inflammation.  
Epidemiological and interventional studies have shown a dose-dependent decrease in risk 
of cardiovascular disease endpoints with increased dietary consumption of moderate 
amounts of omega-3 fatty acids, either plant or marine derived [126].  Cardio-protective 
properties of omega-3 fatty acids include down-regulation of proinflammatory and 
proatherogenic genes, including adhesion molecules and cytokines, during early 
atherogenesis and possibly also during later stages of plaque development and plaque 
rupture [130].  For example, an α-linolenic acid-rich oil decreased oxidative stress and 
CD40 ligand in patients with mild hypercholesterolemia [131], reduced levels of soluble 
cell adhesion molecules in plasma [132] and recurrence of coronary heart disease [133]. 
Randomized trials have reported that after α-linolenic acid supplementation reached the 
ω-6 to ω-3 fatty acids ratio 1.3:1, a significant reduction of c-reactive protein and 
interleutin-6 levels were observed [204].   
The mechanisms by which cytokines and environmental chemicals induce 
endothelial cell activation, oxidative stress and inflammation are not fully understood.  
Oxidative stress-induced transcription factors, which regulate inflammatory cytokine and 
adhesion molecule production, play critical roles in the induction of inflammatory 
responses.  One of these transcription factors, nuclear factor κB (NF-κB), plays a 
significant role in these regulatory processes [115].  Binding sites for NF-κB and related 
transcription factors were identified in the promoter regions of a variety of inflammatory 
genes [116, 117] such as interleukin 6 (IL-6), vascular cell adhesion molecule-1 (VCAM-
1) or cyclooxygenase-2 (COX-2), all of which are up-regulated during PCB toxicity [104, 
197, 205, 206] 
Of increasing recognition is the paradigm that nutrition can modulate the toxicity 
of environmental pollutants and thus affect health and disease outcome associated with 
chemical insult [200].  The current study was designed to test the hypothesis that PCB-
induced endothelial cell inflammation can be enhanced by omega-6 fatty acids and 
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antagonized by omega-3 fatty acids.  We focused on omega-6 and omega-3 fatty acids, 
which are most commonly consumed in the average U.S. diet [129]. 
 
Materials and Methods 
Cell culture and experimental media 
Endothelial cells were isolated from porcine pulmonary arteries and cultured as 
previously described [30].  Arteries obtained during routine slaughter were donated from 
the College of Agriculture, University of Kentucky.  The basic culture medium consisted 
of medium 199 (M-199) (GIBCO Laboratories, NY) containing 10% (v/v) fetal bovine 
serum (FBS, HyClone Laboratories, UT).  The experimental media were composed of M-
199 enriched with 5% (v/v) FBS and with different ratios of linoleic acid (LA) to α-
linolenic acid (ALA) (＞ 99% pure; Nu-Chek Prep, MN).  Preparation of experimental 
media with LA and ALA were performed as described earlier [136].  Different ratios of 
LA to ALA were 2:1, 1:1, and 1:2 (v/v), and the total concentration of fatty acids in all 
the cultures did not exceed 20 µM.  Following the pretreatment with fatty acids for 18 h, 
cells were exposed to coplanar PCB77 for indicated times (6 to 24 h).  In NF-κB 
inhibition studies, cells were first pre-enriched with 50 μM PDTC (EMD Biosciences, 
Inc., CA) for 4 h, then treated with PCB77 or LA.   
 
PCB77 solution 
PCB77 was solubilized in DMSO (sterile-filtered, Sigma-Aldrich, MO) and the 
final concentration in the cell culture media was 3.4 μM.  This level was chosen because 
it has been reported in serum after acute exposure to PCBs [207, 208].  The final 
concentration of DMSO in the culture media did not exceed 0.03%.  All vehicle controls 
and PCB treated cultures contained the same amount of DMSO.  On the other hand, 
controls for fatty acid experiments did not contain DMSO.   
 
Analysis of PGE2 synthase gene expression by real-time PCR 
Total RNA was extracted from endothelial cells using RNA-STAT-60 (TEL-
TEST, Friendswood, TX) according to the manufacturer’s protocol.  Reverse 
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transcription was performed using the AMV reverse transcription system (Promega, 
Madison, WI). The levels of mRNAs and the PCR-product were then assessed by real-
time PCR using 7300 Real Time PCR System (Applied Biosystems).  Real-time PCR 
samples were mixed with SYBR Green Master Mix (Applied Biosystems) and PGE2 
specific primers.  The sequences for porcine PGE2 gene were designed by Primer Express 
Software 3.0 for real-time PCR (Applied Biosystems).  PGE2 sequences: sense, 5’-GCC-
TGAGCGTCTGTGTTTTTTA-3’; antisense, 5’-GCACCTGAATCCTCAAGGACAT-3’.  
β-actin was used as a housekeeping gene.  β-actin sequences: sense, 5’-
TCATCACCATCGGCAACG-3’; antisense, 5’-TTCCTGATGTCCACGTCG-3’. 
 
Statistical analysis 
Values are reported as mean ± standard error of the mean (SEM) of at least three 
independent groups. Data were analyzed using Sigma Stat software (Jandel Corp., Wan 
Rafael, CA). One way ANOVA followed by post hoc least significant difference (LSD)’s 
pairwise multiple comparison procedure were used for statistical analysis of the original 
data.  A statistical probability of p< 0.05 was considered significant.  In figure 4.8, * 
represent significant differences among treatment groups.  In all the other figures, 
different letters represent significant differences among treatment groups.  Capital or 
small letters represent with or without PCB77 respectively as were compared separately 
by one way ANOVA. 
 
 
Results  
Different ratios of linoleic acid to α-linolenic acid modulate cellular oxidative stress 
induced by exposure to PCB77  
To assess the effects of changing relative amounts of linoleic acid (LA) to α-
linolenic acid (ALA) on oxidative stress generation in the absence and presence of 
PCB77, endothelial cells were incubated with different ratios of LA to ALA for 24 h 
without PCB77 exposure, or pre-incubated with different ratios of LA to ALA for 18 h 
and then exposed to PCB77 for an additional 6 h.  This 6 h incubation time was 
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determined from our previous study [106].  As indicated in Fig. 4.1, in the absence of 
PCB77, LA significantly induced oxidative stress as observed by DCF fluorescence 
compared with control cells.  When increasing the relative amount of ALA, a significant 
decrease in oxidative stress was observed in all groups containing more ALA than LA.  
In the PCB77 treatment group, oxidative stress was increased significantly compared 
with the control group, and pretreated cells with LA followed by PCB77 further induced 
oxidative stress compared with cells that were treated only with PCB77 or LA.  
Replacing LA with relative increasing amounts of ALA significantly reduced the additive 
effect of both LA and PCB on oxidative stress.  Furthermore, cells pretreated with ALA 
followed by exposure to PCB77 blocked the oxidative stress induced with PCB77 
treatment alone. 
 
Different ratios of linoleic acid toα-linolenic acid modulate PCB77-induced NF-κB DNA 
binding activity  
Oxidative stress can alter gene expression via the activation of redox sensitive 
transcription factors such as NF-κB [209].  Previous studies in our lab have demonstrated 
that treatment of PCB77 for 3 h can activate NF-κB, but the highest activation at 
approximately 6 h [106].  In the current study, we further investigated the effects of 
changing the relative amounts of LA to ALA on PCB77-induced NF-κB activation.    
First, endothelial cells were incubated with different ratios of LA to ALA for 6 h.  As 
shown in Fig. 4.2, LA significantly induced NF-κB activation.  When introducing ALA 
into the media, the activity of NF-κB significantly decreased compared with cells treated 
with only LA.  As indicated in Fig. 4.3, cells were also pretreated first with different 
ratios of LA to ALA for 18 h, followed by exposure to PCB77 for an additional 6 h.  
Compared to the control group, exposure to PCB77 significantly increased NF-κB DNA 
binding activity and this effect of PCB77 was further increased in the presence of 
supplemental LA.  When introducing ALA into the media, the activity of NF-κB 
significantly decreased compared with cells treated with only LA plus PCB77.  When 
cultures were pretreated only with ALA, a PCB77-induced increase in NF-κB DNA 
binding was completely blocked when compared with the control group. 
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Different ratios of linoleic acid toα-linolenic acid modulate PCB77-induced VCAM-1 
expression 
NF-κB is critical in the regulation and expression of inflammatory genes, such as 
adhesion molecule VCAM-1.  Expression of VCAM-1 on endothelial cells represents one 
of the early pathological changes in immune and inflammatory diseases, such as 
atherosclerosis [210].  We investigated whether PCB77-induced VCAM-1 expression 
was mediated by changing the ratios of LA to ALA.  As indicated in Fig. 4.4, VCAM-1 
gene expression, measured by real-time PCR, was up-regulated after exposure to PCB77.  
LA pre-treatment alone followed by PCB77 increased VCAM-1 gene expression, which 
was reduced with a relative increase in ALA.  This real-time PCR data was confirmed by 
measuring VCAM-1 protein levels by western blot (Fig. 4.5).  
 
PCB77 modulate three enzymes participating in PGE2 synthesis  
The biosynthesis of prostaglandin E2 (PGE2), a major lipid-derived inflammatory 
mediator, involves three enzymatic reactions including phospholipase A2 (PLA2), COX, 
and PGE2 synthase.  To assess the effect of PCB77 on PGE2 production, we first 
measured the activation of cPLA2.  As shown in Fig. 4.6, PCB77 induced an increase of 
cPLA2 phosphorylation at 8 h treatment.  Similarly, COX-2 which catalyzes the rate 
limiting step for PGE2 production was also increased by PCB77 at 8 h (Fig. 4.7).  
Furthermore, the gene expression of PGE2 synthase was significantly increased after 24 h 
of PCB77 treatment (Fig. 4.8).   
 
Different ratios of linoleic acid toα-linolenic acid modulate PCB77-induced COX-2 
expression and subsequent PGE2 production 
COX-2 is an inducible pro-inflammatory enzyme controlled by NF-κB [211].  To 
assess whether different ratios of LA to ALA can modulate PCB77-induced COX-2 up-
regulation, real time RT-PCR was performed on total cell RNA.  Similar to the NF-κB 
data, PCB77-induced COX-2 mRNA levels were attenuated by increasing relative 
amounts of ALA (Fig. 4.9).  These data were confirmed by measuring protein levels of 
COX-2 by western blot (Fig. 4.10).   
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The inducible COX-2 isoform plays a key role in inflammation and is the rate-
limiting enzyme for prostaglandin synthesis.  In order to assess COX-2 activity, we 
measured PGE2 production.  As shown in Fig. 4.11, PCB77 significantly induced PGE2 
production in a time-dependent manner.  We also pretreated cells with different ratios of 
LA to ALA for 18 h followed by exposure to PCB77 for an additional 24 h.  As indicated 
in Fig. 4.12, compared to the control group, LA significantly increased PGE2 production, 
which was further enhanced by PCB77 exposure.  Substituting relative amounts of LA 
with ALA markedly decreased the PCB-induced PGE2 production. 
 
Inhibition of NF-κB decreases PCB77- and linoleic acid-induced VCAM-1 and COX-2 
expression  
In order to confirm that NF-κB is a critical transcription factor in PCB77-induced 
endothelial inflammatory response as modulated by fatty acids, we studied the effect of 
pyrrolidine dithiocarbamate (PDTC), an antioxidant, markedly inhibited the activation of 
NF-κB, on both PCB77- and LA-mediated VCAM-1 and COX-2 expression by real time 
RT-PCR.  As shown in Fig. 4.13 and 4.14, PDTC significantly decreased PCB77- and 
LA-induced VCAM-1 and COX-2 expression, respectively.  These results clearly 
indicate that NF-κB is crucially involved in linoleic acid and PCB77 modulated 
endothelial cell activation.   
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Figure 4.1  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced oxidative stress 
 
Cultures were incubated in media supplemented with 20 μM fatty acids, either all linoleic 
acid (LA), all α-linolenic acid (ALA), or different ratios of LA to ALA (R2:1, R1:1, R1:2) 
for 24 h.  Some cultures were first pre-treated with these different ratios of fatty acids for 
18 h, followed by co-exposure to 3.4 μM PCB77 for additional 6 h.  Values are means ± 
SEM (n = 3).  Statistical comparisons of the two experimental settings (without and with 
added PCB77) are indicated by small and capital letters.  Different letters represent 
significant differences among the treatment groups.   
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Figure 4.2  Effect of different ratios of linoleic acid to α-linolenic acid on the activation 
of NF-κB 
 
Cells were treated with 20 μM of linoleic acid (LA), α-linolenic acid (ALA), or different 
ratios of LA to ALA (R2:1, R1:1, R1:2) for 6 h.  Experiments were repeated three times, 
and the blots shown are a representative of one of the experiments.  The bar graph shows 
the corresponding densitometric analysis of the blots.  Values are means ± SEM.  
Different letters represent significant differences among treatment groups. 
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Figure 4.3  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced activation of NF-κB 
 
Cells were treated with 20 μM of linoleic acid (LA), α-linolenic acid (ALA), or different 
ratios of LA to ALA (R2:1, R1:1, R1:2) for 18 h prior to exposure to 3.4 μM PCB77 for 
an additional 6 h.  Experiments were repeated three times, and the blots shown are a 
representative of one of the experiments.  The bar graph shows the corresponding 
densitometric analysis of the blots.  Values are means ± SEM.  Different letters represent 
significant differences among treatment groups. 
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Figure 4.4  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced VCAM-1 gene expression 
 
Endothelial cells were pretreated with 20 μM of linoleic acid (LA), α-linolenic acid 
(ALA), or different ratios of LA to ALA (R2:1, R1:1, R1:2) for 18 h and then exposed to 
3.4 μM PCB77 for additional 6 h for VCAM-1 mRNA measurement.  β-actin was used 
as a housekeeping gene.  Experiments were repeated three times.  Values are means ± 
SEM.  Different letters represent significant differences among treatment groups. 
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Figure 4.5  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced VCAM-1 protein expression 
 
Endothelial cells were pretreated with 20 μM of linoleic acid (LA), α-linolenic acid 
(ALA), or different ratios of LA to ALA (R2:1, R1:1, R1:2) for 18 h and then exposed to 
3.4 μM PCB77 for additional 8 h.  β-actin was used as a housekeeping gene.  
Experiments were repeated three times, and the blots shown are a representative of one of 
the experiments.  Values are means ± SEM.  Different letters represent significant 
differences among treatment groups. 
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Figure 4.6  Effect of PCB77 on cPLA2 phosphorylation 
 
Cells were exposed to 3.4 μM PCB77 for indicated time.  Phosphorylated cPLA2 was 
measured by phosph-cPLA2 specific antibody.  β-Actin was used as a housekeeping gene.  
Experiment was repeated twice as shown. 
 
 
 
 
 
Figure 4.7  Effect of PCB77 on COX-2 expression 
 
Cells were exposed to 3.4 μM PCB77 for 6 h.  COX-2 protein levels were measured by 
western blot.  β-Actin was used as a housekeeping gene.  Experiment was repeated twice 
as shown. 
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Figure 4.8  Effect of PCB77 on PGE2 synthase expression 
 
Cells were exposed to 3.4 μM PCB77 for indicated time.  PGE2 synthase gene 
expression was measured by real-time PCR.  β-Actin was used as a housekeeping gene.  
Experiments were repeated three times.  Values are means ± SEM.  * represents 
significant difference among treatment groups. 
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Figure 4.9  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced COX-2 gene expression 
 
Cells were pretreated with 20 μM of linoleic acid (LA), α-linolenic acid (ALA), or 
different ratios of LA to ALA (R2:1, R1:1, R1:2) for 18 h and then exposed to 3.4 μM 
PCB77 for additional 6 h.  β-Actin was used as a housekeeping gene.  Experiments were 
repeated three times.  Values are means ± SEM.  Different letters represent significant 
difference among treatment groups. 
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Figure 4.10  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
induced COX-2 protein expression 
 
Cells were pretreated with 20 μM of linoleic acid (LA), α-linolenic acid (ALA), or 
different ratios of LA to ALA (R2:1, R1:1, R1:2) for 18 h and then exposed to 3.4 μM 
PCB77 for additional 8 h.  β-Actin was used as a housekeeping gene.  Experiments were 
repeated three times, and the blots shown are representative of one of the experiments.  
Values are means ± SEM.  Different letters represent significant difference among 
treatment groups. 
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Figure 4.11  Optimal PCB77 incubation time for PGE2 production 
 
Cells were exposed to 3.4 μM PCB77 for 6, 18 and 24 h.  Supernatants of cell cultures 
were collected and PGE2 levels were measured by enzyme immunoassay (EIA).  Bars 
represent means ± SEM from three independent experiments.  Different letters represent 
significant difference among treatment groups. 
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Figure 4.12  Effect of different ratios of linoleic acid to α-linolenic acid on PCB77-
stimulated release of PGE2  
 
Cells were incubated in media supplemented with 20 μM fatty acids, either all linoleic 
acid (LA), all α-linolenic acid (ALA), or different ratios of LA to ALA (R2:1, R1:1, R1:2) 
for 18 h.  Some cultures were first pre-treated with these different ratios of fatty acids for 
18 h, followed by co-exposure to 3.4 μM PCB77 for additional 24 h.  PGE2 levels were 
measured by enzyme immunoassay.  Bars represent means ± SEM from three 
independent experiments.  Statistical comparisons of the two experimental settings 
(without or with added PCB77) are indicated by small or capital letters.   
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Figure 4.13  Effect of NF-κB inhibitor on PCB77- or linoleic acid-induced VCAM-1 
expression 
 
Cells were exposed to 3.4 μM PCB77 or 20 μM linoleic acid (LA) alone for 6 h, or first 
pre-enriched with 50 μM PDTC for 4 h followed by coexposure to PCB77 or LA for 
additional 6 h.  PCB77- or LA-induced VCAM-1 mRNA levels, as measured by real-time 
RT-PCR.  β-Actin was used as a housekeeping gene.  Experiments were repeated three 
times.  Values are means ± SEM.  Different letters represent significant difference among 
treatment groups. 
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Figure 4.14  Effect of NF-κB inhibitor on PCB77- or linoleic acid-induced COX-2 
expression 
 
Cells were exposed to 3.4 μM PCB77 or 20 μM linoleic acid (LA) alone for 6 h, or first 
pre-enriched with 50 μM PDTC for 4 h followed by coexposure to PCB77 or LA for 
additional 6 h.  PCB77- or LA-induced COX-2 mRNA levels, as measured by real-time 
RT-PCR.  β-Actin was used as a housekeeping gene.  Experiments were repeated three 
times.  Values are means ± SEM.  Different letters represent significant difference among 
treatment groups. 
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Figure 4.15  Proposed mechanism for fatty acid-mediated modulation of endothelial cell 
activation induced by PCB77 
 
Omega-6 or omega-3 fatty acids can either enhance or reduce PCB77-induced up-
regulation of oxidative stress and activation of NF-κB.  Relative activation of NF-κB will 
further regulate VCAM-1, as well as COX-2 enzyme activity and subsequent PGE2 
release from endothelial cells. 
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Discussion  
Exposure to environmental toxicants such as persistent organic pollutants can 
significantly compromise heath, and there is evidence that PCBs are proatherogenic.  In 
fact, epidemiological studies with humans demonstrate a link between cardiovascular 
diseases and exposure to environmental pollutants.  For example, an increase in 
hospitalization rates was reported for coronary heart disease in populations residing near 
areas contaminated with persistent organic pollutants [196].  Endothelial cells which line 
the inner layer of blood vessels are an important cell type involved in the regulation of 
metabolic events associated with the pathology of atherosclerosis.  Dysfunction of the 
vascular endothelium is considered to be a critical underlying cause of the initiation of 
cardiovascular diseases such as atherosclerosis [6].  Environmental toxicants, once 
absorbed, distribute themselves to tissues, especially adipose, where they are in dynamic 
equilibrium with the blood.  Thus, risk factors of pollutants such as PCBs are chronic and 
can continuously amplify pathologies of diseases that are associated with endothelial 
dysfunction.  Data from our present study confirm that endothelial exposure to PCB77 
provides a prooxidative cellular environment, sufficient to induce oxidative stress-
sensitive transcription factors such as NF-κB and associated inflammatory events 
characteristic of early events in the pathology of atherosclerosis. 
The diet is a major route of exposure to environmental toxic pollutants, such as 
persistent organic pollutants, including PCBs.  Since many of these pollutants are fat 
soluble, fatty foods are not only unhealthy risk factors by themselves, but they usually 
contain higher levels of persistent organics than vegetable matter [109].  Thus, high-fat 
foods may pose as multiple risk factors in contributing to diet-derived proatherogenic 
lipids as well as environmental toxicants.  Since omega-6 rich oils are prooxidative and 
can amplify PCB-mediated dysfunction of endothelial cells [106], and since omega-3 rich 
oils exhibit cardio-protective properties [126, 130], we were interested in comparing the 
effect of linoleic acid (the parent omega-6 fatty acid) and α-linolenic acid (the parent 
omega-3 fatty acid) on modulating PCB-mediated endothelial inflammatory events.  
Linoleic acid is the major fatty acid in common vegetable oils, and current estimates 
indicate that over 90% of the omega-3 consumed by U.S. citizens is in the form of α-
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linolenic acid, not the longer chain omega-3 fatty acids found in fish oils [129].  
Nevertheless, many types of fish which are an excellent source of long-chain omega-3 
fatty acids are often contaminated with persistent organic pollutants such as PCBs.  
Whether the cardio-protective omega-3 fatty acids in fish neutralize or markedly decrease 
the potential health risks associated with exposure to persistent organic pollutants is not 
known.  There appears to be some consensus that regular fish consumption should be 
encouraged for its overwhelming cardio-protective properties [212, 213]. 
Using an established cell culture model, our data clearly demonstrate that 
increasing the relative amount of α-linolenic acid (ALA) over linoleic acid (LA) protects 
against PCB-mediated endothelial activation.  We have previously observed that linoleic 
acid can amplify PCB-mediated dysfunction of vascular endothelial cells [106].  We also 
have demonstrated that antioxidants such as vitamin E can protect against PCB-mediated 
endothelial cell activation [99].  There is increasing evidence that nutrition can dictate the 
lipid milieu, oxidative stress and antioxidant status within cells, and thus modulate 
mechanisms of cytotoxicity mediated by environmental pollutants [199].  Many 
environmental pollutants induce signaling pathways that respond to oxidative stress and 
lead to inflammatory events; and many of these same pathways are associated with the 
etiology and early pathology of many chronic diseases [214].   
Our data support the hypothesis that the lipid milieu within the vascular 
endothelium can either upregulate or downregulate inflammatory events induced by 
PCB77.  We have shown previously that 18-carbon fatty acids differing in degree of 
unsaturation selectively induce an inflammatory environment in human endothelial cells 
[215].  Of the fatty acids studied, linoleic acid stimulated NF-κB transcriptional 
activation the most.  In addition, treatment with this fatty acid markedly enhanced mRNA 
levels of TNF-α, monocyte chemoattractant protein 1 (MCP-1) and adhesion molecules 
such as VCAM-1 [215].  In contrast, treatment with α-linolenic acid had minimal effects 
on these inflammatory markers.  Interestingly, in the current study, a relative increase in 
α-linolenic acid over linoleic acid markedly reduced inflammatory markers induced by 
exposure to PCB77. 
Mechanisms of the lipid and PCB interactions on endothelial inflammatory events 
are not clear, but our data suggest that NF-κB is a critical player in the overall regulation 
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of these events.  We have previously demonstrated that PCB77-mediated activation of 
NF-κB can be blocked by pretreatment with pyrrolidine dithiocarbamate (PDTC), 
suggesting regulatory functions of PCB-induced endothelial cell activation through NF-
κB signaling [99].  In the present study, we demonstrated that inhibition of NF-κB 
markedly reduced both PCB and linoleic acid -mediated endothelial inflammation.  NF-
κB binds to and affects the function of several genes encoding proteins mediating 
inflammation, and inhibition of NF-κB by PDTC resulted in reduced neutrophil 
infiltration in lungs, liver and hearts of rabbits infused with lipopolysaccharide (LPS) 
[216].  A recent study demonstrated that inhibition of NF-κB in aged vessels significantly 
attenuated inflammatory gene expression and inhibited monocyte adhesiveness [217]. 
Protective mechanisms of omega-3 fatty acids on down-regulation of PCB-
induced vascular inflammation are not well understood.  PCBs have been reported to 
induce arachidonic acid release in human platelets [218], and in rat amnion fibroblast 
cells [219] with a subsequent increase in eicosanoid formation.  Our data suggest that 
linoleic acid can enhance and α-linolenic acid inhibit these events.  One inhibitory 
mechanism may be a relative decrease in substrate availability for PGE2 formation during 
cellular enrichment with α-linolenic acid [220].  Others have reported that 
eicosapentaenoic acid can inhibit TNF-α induced endothelial cell inflammation via 
PI3K/Akt signaling pathways [221], pathways which also can regulate NF-κB DNA 
binding [105].  Omega-3 fatty acids also have been shown to inhibit NF-κB activation via 
peroxisome proliferators-activated receptor alpha signaling [222].   
A recent human study demonstrated that if intake of ω-3 fatty acid (such as ALA) 
is sufficient, the ω-6 fatty acid intake can be increased without causing pro-inflammatory 
response [223].  ALA is the most commonly consumed ω-3 fatty acid in Western diets.  
Thus, strategies to increase ALA in the diet are important for the perspective of vascular 
inflammation to reduce atherosclerosis. 
In summary, the current study demonstrates that diet-derived lipids can modulate 
PCB77 stimulated activation of endothelial cells by affecting oxidative stress sensitive 
signaling pathways (Fig. 4.15), including activation of NF-κB and up-regulation of 
inflammatory genes.  Our data contribute to the paradigm that nutrition can modulate the 
 92  
 
 
  
toxicity of environmental pollutants and thus affect health and disease outcome 
associated with chemical insult [200].  Whether an increase in the consumption of 
omega-3 polyunsaturated fatty acids can be used therapeutically against inflammation 
that is mediated in part by environmental pollutants warrants further study.  
 
 
Copyright © Lei Wang 2007 
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Chapter Five : Summary  
Conclusion 
Overall, the initiation of atherosclerosis by endothelial cell activation is mediated 
by complex interactions between circulating nutrients, cytokines and environmental 
pollutants.  In the current work we studied the effects of different dietary omega-6 and 
omega-3 fatty acids on cytokine and pollutant-induced endothelial cell activation.  We 
have previously shown that linoleic acid, the major omega-6 fatty acid in the American 
diet potentiated both TNF-α and PCB-induced endothelial cell activation [106, 107, 156].  
In contrast, omega-3 fatty acids from fish oil have been shown to have anti-atherogenic 
effects.  But the beneficial effect of α-linolenic acid which is actually the major omega-3 
fatty acid in the diet has not been well studied yet.  Considering these findings the 
hypothesis was tested that the induction of endothelial cell activation may be modulated 
differentially by linoleic or α-linolenic acids during both TNF-α and PCB77 stimulation. 
Activation of endothelial cells and associated inflammatory events are critical 
underlying causes of the initiation of cardiovascular diseases such as atherosclerosis [6].  
The mechanisms by which selected fatty acids induce endothelial cell activation, 
oxidative stress and inflammation are not fully understood.  Oxidative stress-induced 
transcription factors, which regulate inflammatory cytokine and adhesion molecule 
production, are important regulatory elements in the induction of inflammatory responses.  
One of these transcription factors, NF-κB, plays a significant role in these regulatory 
processes [115].  Binding sites for NF-κB and related transcription factors were identified 
in the promoter regions of a variety of inflammatory genes [116, 117]. 
Our data in chapters 2 and 4 indicate that both TNF-α and PCB77 can induce up-
regulation of oxidative stress, NF-κB activation and NF-κB-dependent induction of 
VCAM-1, COX-2, and a subsequent increase in PGE2 production.  All of these events 
were amplified by pre-enrichment with linoleic acid but blocked or reduced by α-
linolenic acid.  Prostanoids represent a group of lipid mediators.  PGE2 is the most 
common prostanoid which is generated at sites of inflammation [224].  The biosynthesis 
of PGE2 involves three enzymatic reactions including phospholipase A2 (PLA2), COX, 
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and terminal PGE2 synthase.  We demonstrated that both TNF-α and PCB77 can activate 
cPLA2 at 8 hour, a similar time point when COX-2 up-regulation was observed.  Both 
cPLA2 and COX-2 have been shown to locate predominantly in the nuclear envelope 
[225, 226], these permit efficient functional coupling between cPLA2 and downstream 
enzyme COX-2.  Furthermore, the time course studies indicated that after 24 hours 
treatment, TNF-α and PCB77 induced significant PGE2 production.  This later response 
might partially due to the late activation of terminal PGE2 synthase, as shown by our real-
time PCR data that PGE2 synthase expression was significantly increased by PCB77 after 
24 hours treatment.   
In chapter 3, we further explored the role of caveolae in fatty acids mediated 
TNF-α-induced inflammatory responses in endothelial cells.  Because a growing body of 
evidence indicates that dietary fatty acids can alter caveolae microenvironment, thereby 
modifying location and function of proteins in caveolae.  Previous study in endothelial 
cell fatty acid composition of caveolae has shown that palmitic acid (16:0), palmitoleic 
(16:1), stearic acid (18:0), together with oleic acid (18:1) compose the 80% of total fatty 
acids, whereas linoleic acid (18:2) composes of 10% of total fatty acids in caveolae [71].  
EPA has been shown to displaces caveolin-1 from caveolae in endothelial cells [72].  
Moreover, caveolin-1, the functional protein of caveolae can bind to many types of 
plasma membrane receptor proteins or membrane associated enzymes and concentrate 
these molecules within caveolae [227].  TNFR-1 has also been shown to concentrate 
within the caveolae of a human endothelial cell line [79].   
Interestingly, our data indicated that functional caveolae are necessary for TNF-α-
mediated activation of endothelial cells.  TNF-α markedly induced caveolin-1 and 
TNFR-1, and both expressions were further induced when cells were first enriched with 
linoleic acid.  In contrast, α-linolenic acid diminished these effects.  These data indicated 
that different fatty acids may modulate both TNFR-1 and caveolin-1 expression, thus 
altering the interaction of the two.  These will in turn profoundly influence TNFR-1 
dependent downstream signaling.  Moreover, silencing caveolin-1 totally blocked TNF-
α-induced COX-2 up-regulation and PGE2 biosynthesis.  Previous studies have shown 
that COX-2 may be localized to caveolae-like structures [228].  COX-2 in human 
foreskin fibroblasts stimulated by IL-1β was localized to plasma membrane in addition to 
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nuclear envelope, and image overlay showed colocalization of COX-2 with caveolin-1 
[80].  These results indicated that caveolae are important cellular platform for TNF-α 
receptor-mediated down stream COX-2 activity.  In contrast, linoleic acid-induced COX-
2 up-regulation and PGE2 production were not altered by caveolin-1 silencing.  Taken 
together, our data indicated that lipid microdomains, and in particular caveolae, may be a 
novel modality mediating the effects of linoleic and α-linolenic acids in response to TNF-
α-mediated inflammatory stimulations, but the inflammatory responses induced by 
linoleic acid appear to be independent of caveolae protein.  It is very likely that selected 
fatty acids either stabilize or perturb caveolae functions, thus leading to modifications of 
caveolae-dependent signaling.   
There is evidence that fatty acids can alter localization and function of caveolae-
associated signaling proteins in mouse colonic mucosa [73].  These data suggests that 
omega-3 fatty acids may in part be anti-inflammatory by decreasing caveolin-1 
expression or by causing dysfunctional caveolae, leading to down-regulation of caveolin-
dependent down-stream signaling.  Moreover, perturbation of membrane raft structural 
integrity with cholesterol-sequestering compounds had been shown to cause 
delocalization of eNOS from caveolae and to inhibit TNF-α-induced ROS production and 
protein tyrosine nitration [229].   
Furthermore, we recently investigated caveolin-1-regulated mechanisms 
associated with PCB-induced markers of peroxynitrite formation and DNA binding of 
NF-κB [230] and demonstrated that caveolin-1 silencing abolished the PCB-stimulated 
NF-κB DNA binding, suggesting a regulatory role of caveolae in PCB-induced 
endothelial cell activation.  Our unpublished data have also shown that PCB treatment 
increased formation of caveolae and PCB77 accumulated mainly in the caveolae-rich 
fraction and AhR, the main molecular target of PCB77 was associated with caveolin-1, 
and the association was increased after PCB77 treatment.  Thus, the broad mediation 
effects of fatty acids appear to be largely due to their role as structural components of 
cellular membranes and are involved in many important cell-signaling pathways.  This 
suggests that a common fundamental mechanism might be involved in the inflammatory 
cytokine TNF-α and environmental pollutant PCB77-triggered pro-inflammatory 
cascades.   
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In summary (Fig. 5.1), we provide novel data demonstrating that omega-6 and 
omega-3 fatty acids can differentially modulate TNF-α and PCB77-induced 
inflammatory stimuli and that these events require functional caveolae.  Furthermore, 
functional changes of caveolae associated with modifications by dietary fatty acids 
appear to affect critical phases of induction of oxidative stress-sensitive transcription 
factors and inducible inflammatory parameters during endothelial cell activation.  
Because caveolae and caveolins have been implicated in several human diseases and in 
particular vascular diseases, our data may have implications in understanding novel 
mechanisms of inflammatory diseases modulated by dietary lipids.  Furthermore, 
research findings present in this dissertation contribute to the paradigm that nutrition can 
modulate the toxicity of environmental pollutants and thus affect health and disease 
outcome associated with chemical insult [200].  Whether an increase in the consumption 
of omega-3 polyunsaturated fatty acids can be used therapeutically against inflammation 
that is mediated in part by environmental pollutants warrants further study.   
 
Future Directions 
The current study demonstrated the critical role of functional caveolae in fatty 
acid-mediated endothelial activation.  Since caveolae contain sphingomyelin and initiate 
the conversion of sphingomyelin to ceramide which is a novel sphingomyelin-derived 
second messenger mediating cellular signals, further studies are needed to clarify the 
effects of fatty acids on caveolae composition and to explore further their role in 
ceramide metabolism (Fig. 5.2).   
A lipid raft membrane is composed of sphingolipids and cholesterol in the 
exoplasmic leaflet, linked to glycerophospholipids and cholesterol in the cytoplasmic 
leaflet of the lipid bilayer [231].  It is possible that long chain fatty acid substituents of 
sphingolipids extend from the outer to the inner leaflet where they interdigitate with the 
saturated side chains of glycerophospholipids and establish a close association [232].  In 
caveolin-1 knockout mice, the transport of glycosylphosphatidylinositol-anchored 
proteins to the cell surface was inefficient, consistent with a role for caveolin in the 
transport of these lipid raft-associated proteins to the plasma membrane [233].  Caveolin-
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1 null mice showed a dramatic increase in serum triacylglycerols and non-ester fatty acid 
levels [227] indicated that caveolae might have a primary role in regulating the lipid 
balance by stimulating fatty acid uptake.  
Lipids are crucial structural and functional components of cells. Even more 
importantly, many lipid species have distinct cellular functions. For example, ceramides, 
eicosanoids, diacylglycerol (DAG) and lysolipids are all second messengers which 
participate in various cellular events such as inflammation, growth, proliferation, 
differentiation and cell death.  Sphingomyelin is one of the major lipids in cell 
membranes and plasma lipoproteins.  In clinical studies, sphingomyelin plasma levels 
have been shown to correlate with the occurrence of coronary heart disease independent 
of plasma cholesterol levels [234].  Previous studies indicated that the endothelium 
contributes to ceramide-induced relaxation possibly through an interaction between 
sphingomyelin hydrolysis and endothelial NO synthase within caveolae [235].  
Furthermore, TNF-α has also been shown to profoundly affect sphingolipid metabolic 
pathways leading to the accumulation of one or more sphingolipids.  For example, TNF-
α transiently increases cellular ceramide by increasing the hydrolysis of sphingomyelin.  
Increased ceramide levels activate ERK [236, 237], JNK [237], MAPKs and NF-κB 
translocation [238].  Sphingomyelin and ceramide both contain one fatty acyl moiety that 
is linked to the sphingosine backbone by an amide bond.  Whether the type of this fatty 
acyl moiety can be altered by dietary fatty acids in endothelial cells has not yet been 
studied.  In our study the different polyunsaturated fatty acid-induced modification in 
response to TNF-α and/or PCB may be due to the changes of the microdomain 
polarization within sphingolipids modified by dietary fatty acids.  However, the effects of 
PCB on ceramide signaling pathways have not been explored yet.   
Thus, future studies of a more detailed involvement of caveolae in the cellular 
regulation of fatty acid-mediated modulation of a vascular inflammatory response may be 
considered.   
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Figure 5.1  Summery  
 
 
 
 
 
Figure 5.2  Future direction 
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Appendix: Protocols 
Primary Culture of Porcine Pulmonary Artery Endothelial Cells 
Obtain tissue:  
A. Supplies:  
1. Sterile: tweezers, scissors, razor blades, sponge gauze, specimen containers, 
gloves, Other supplies: 3 beakers (250 ml); 
2. Media and solutions: M199+3xP/S (warm up to 37℃), 70% ethanol 
B. Obtain tissue: 
1. Take the heart of porcine during routine slaughter at the College of Agriculture.  
Find pulmonary artery which is next to aorta.  Gently separate aorta and 
pulmonary artery using the other side of scissors.  Try not to squeeze vessels too 
hard.   
2. After separation, use intestinal forceps to clamp artery at the end nearest the heart.  
Cut the vessel off at the edge of clamp, then with the clamps still on, dip artery in 
the 70% ethanol solution and then dip into M199+3xP/S. 
3. Take off the clamps, put artery into a sterile specimen cup with enough 
M199+3xP/S to cover the whole artery.  Label the container, and place on ice 
carry back to the lab and put in 4 ℃.   
Culture cells (should be done completely inside the hood): 
A. Supplies 
1. Sterile: culture dishes, tweezers, allis intestinal forceps, sponge gauze, centrifuge 
tubes, scapel, scissors, plugged Pasteur piptes, plastic transfer pipets, measuring 
pipets, cotton swabs with wooden stick, T25 tissue culture flasks. 
2. Media and solutions: M199+3xP/S and M199+10% FBS (both warmed up to 37
℃).  Fill two 250 ml beakers with 70% ethanol and one 250 ml beaker with 
M199+3xP/S.   
3. Collagenase solution: will need 2 ml for each artery.  Add 1 mg of collagenase per 
ml of Hanks buffer (warm up to 37℃).  Vortex the solution and centrifuge at 
2500 rpm for 10 min.  Filter supernatant using a syringe filter unit (0.22 μM). 
B. Isolation of endothelail cells 
1. Take artery from specimen container and place on Hanks moisturized sterile 
sponge gauze (handle artery with steriled tweezers, don’t touch it with hands). 
Use a Pasteur pipet to rinse the inside of the artery with M199 to get off blood 
clots and blood cells and avoid touching the inside of the artery.  Then use a 
forcep and tweezers to clamp one end of the artery.  Use a pasteur pipet fill from 
the open end of the artery with collagenase solution and clamp it up with another 
forcep.  Wait for 5 min. 
2. During the waiting time, add 2 ml of M199+10% FBS into each of two 30 mm 
tissue culture dishes (swab twice for each artery), and label with cell line, date, 
and number of swab (1 or 2).  When the 5 min are over, release forceps and dry 
collagenase solution into sterile sponges.  Rinse inside of artery with a pasteur 
pipet full of M199+10%FBS and place artery on a dry, sterile gauze pad.  Cut 
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artery open length wise with a pair of sharp sterile scissors, avoid touching other 
area of the artery besides the cutting line. 
3. Wet a sterile cotton swab in the media from the 30 mm tissue culture dish labeled 
swab1.  Very gently rub the swab over the inside surface of the artery.  Do not put 
any pressure on the swab and avoid swabbing where the forceps clamped or over 
the same place twice or at the edge of the artery.  Make about two rounds 
swabbing and then stir the swab around in the media and press it against the sides 
to release the endothelial cells into the media.  Repeat this with a new swab and 
put into the dish labeled with swab 2. 
4. Place culture dishes into the incubator.  4 h later, use the aspirator to remove the 
media and replace it with 2 ml of new 37℃ M199+10%FBS media.  Change 
media again at 24 or 48 h after this depends on how many cells are attached. 
5. 4 or 5 days later, when the cells get confluent, pass one 30 mm dish into one T25 
tissue culture flask (passage 1). When it gets confluent, pass one T25 into one T75 
flask (passage 2).  Later pass one T75 into one T225 or three T75 (passage 3).  
Usually freeze cells at passage 4 or 5.  Isolated primary endothelial cells can be 
used up to 15 passages. 
Freeze Endothelial Cells 
One confluent T-75 flask can be frozen into 2 cryotubes.   
One T-225 flask can be frozen into 6 cryotubes. 
1. For one T-75 flask: rinse cells with 10ml hanks then add 1 ml trypsin.  Can do 
two T-75 at one time.  When cells are detached, add 10ml 10% M199 and transfer 
into a 15ml conical tubes.   
2. For one T-225 : Trypsinized cells with 1.5 ml trypsin. add 30 ml 10% M199 and 
transfer into three 15 ml conical tubes. 
3. Centrifuge at 1200rpm for 10 min (at 37℃).  Decant supernatant (gently) and add 
2 ml freezing cocktail* into each conical tube.  Gently mix the cells with freezing 
cocktail.  Transfer to 2 cryotubes with 1 ml each (tubes should be properly 
labeled with passage, date and operator).   
4. Keep tubes between two foam layers in -20℃ overnight or in “Slow Freeze 
Apparatus (isopropano jacketed container)” for 24 h, then put in -80℃.  After at 
least 18 h in -80℃, put cryotubes in liquid nitrogen tank. 
 
*Freezing cocktail must be made fresh each time: 
Every T-75 flask needs 2 ml of freezing cocktail, prepare a little extra (plus 2ml).  
Warm up everything to 37 C before using. 
 1ml For 8 T75 
prepare 18 ml 
For 9 T75 
prepare 20 ml 
For 18 T75 
prepare 38 ml 
28% DMSO (ml) 0.25 4.5 5 9.5 
FBS (ml) 0.2 3.6 4 7.6 
M199 (ml) 0.55 9.9 11 20.9 
Preparation of 28% DMSO in M199: 
 1 ml 4.5 ml 5 ml 10 ml 
DMSO (ml) 0.28 1.26 1.4 2.8 
M199 (ml) 0.72 2.24 3.6 7.2 
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Start a Frozen Endothelial Cell Line 
1. Warm up M199+10%FBS media to 37℃and set centrifuge to 37 ℃ in ahead. (To 
achieve the temperature quicker, can set the temperature to 40℃, speed to 3000 rpm, 
and let run for 10 min)  
2. Take one cryotube of frozen cells from liquid N2 tank or -80℃ freezer at one time.   
3. Add 9 ml media into a 15 ml conical tube for one cryotube.  Use a 5 ml pipet get 1 ml 
media from the conical tube put it quickly up and down into cryotube to thaw the 1 
ml freezing cocktail with endothelial cells.  Put the resolved part into the conical tube 
and get some fresh and warm media from the same tube, up and down again until get 
all the liquid out from the cryotube.   
4. Centrifuge at 2000 rpm for 5 min immediately.  Don’t leave cells with freezing 
cocktail at room temperature for too long.  Then use the aspirator to remove the 
media and freezing cocktail, put 1 ml of fresh media and gently scatter the pellet of 
cells.  Add 9 ml of media to conical tube and centrifuge for 5 min again.  Remove the 
media after centrifuge, repeat the scatter and mix cells with 10 ml of media.  Place the 
cell suspension into one T75 cell culture flask.  Change media 4 h after revival or 
change media in the following morning depends on how many cells attached. 
 
Cell Culture and Experimental Media 
A. Cell culture 
Pass the cells: 
1. It will usually take two days for cells to grow confluent.  When cells are ready, 
use the aspirator to remove old media.  Add 6 ml of Hanks for a T75 flask and 10 
ml for T225.  Gentely tilt the flask to rinse all the cells.  Remove Hanks buffer 1 
after 1 min incubation at room temperature. 
2. Add trypsin (1 ml for the T75 and 2 ml for the T225 flask).  Place in the incubator 
for 2 to 3 minutes.  Then strike the side of flask to detach the cells and check 
under the microscope to see whether all cells are detached as little round circle.  . 
3. While cells are in the trypsin incubating, add medium to new flasks (7 ml for the 
T75 and 20 for the T225), and label with “P#” for the passage, and date.  
4. After the cells are detached gentlely add 12 ml of medium (for T75) or 30ml of 
medium (for T225), up and down avoid air bubble.  Usualy one T75 can be 
passed into 3 T75 or one T225.  One T225 can be passed into 3 T225.  Add 4 ml 
(for T75) or 10 ml (for T225) of the re-suspended cells to each new flask. 
5. Place flasks in the incubator. 
Plating the cells:  
1. Ratio of cell suspension and media for plates and flasks 
100 mm culture dishes can hold up a total volume of 10 ml (3 ml of the cell 
suspension plus 7 ml of medium) 
60 mm dishes can hold a total volume of 3 ml (1 ml of the cell suspension plus 2 ml 
of medium).  
After plating, it usually takes about 48 h for cells to get confluent. 
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T-75 flask can be passed into three T-75, one T-225, four 100 mm plates, or twelve 
60 mm plates. 
T-225 flask can be passed into three T-225, twelve 100 mm plates, or thirty six 60 
mm plates. 
2. Plating cells on multiple well plates 
No matter the multiple-well plate has how many wells, the whole plate usually can 
hold up to 12 ml of total media volume.  This will need 4 ml of the cell suspension 
plus 8 ml of media.  Usually use T-75 flask to plate.  Always make the 12 ml of the 
cell and medium mixture first before divided into each well.  For a 6 well plate: 12 
divided by 6, so put 2 ml of the mixture into each well.  For a 12 well plate: put 1 ml 
into each well.  For a 24 well plate: put 0.5 ml et al. 
B. Preparation of Media and Hanks 
1. M199+AA: 
Add 2 pouches of the media (M199, Gibco Cat No 31100-035) 
Add 4.4g of NaHCO 
Add 2 L of autoclaved (dI H2O) 
Add 2ml of NaOH (6N same as 6M) 
Add 40 ml of amino acids (premade solution from Gibco) 
Mix well and adjust pH to 7.4  
2. Hanks 
KCl: 0.8g 
KH2PO4: 0.12g 
NaCl: 16g 
NaHCO3: 0.7g 
Na2HPO4 * 7H2O: 0.18g 
D glucose: 2.0g 
Phenol Red: 0.02g 
Add 2 L of autoclaved H2O adjust pH to 7.4 and then filter. 
3. Trypsin 
Remove 40ml of Hanks (new un-used bottle that has 400 ml total) 
Add 40 ml of trypsin to the remaining 360 ml of Hanks. Swirl and make 12 ml 
aliquots 
4. 10 % or 5% FBS M199 
For 10% media: Take out 52 ml of the M199 media from 400ml into another bottle 
and add 4ml of P/S (penicillin streptomycin, Cat No 15140-122), 4 ml of L-glutamine 
(Cat No 25030-156), 4 ml of MEM amino acids (GIBCO Cat. No. 11130-051), and 
40 ml of FBS (fetal bovine serum). 
 
For 5% media: Take out 32 ml of the M199 media and add 4ml of P/S (penicillin 
streptomycin, Cat No 15140-122), 4 ml of l-glutamine (Cat No 25030-156), 4ml of 
MEM amino acids (GIBCO Cat. No. 11130-051) and 20 ml of FBS (fetal bovine 
serum) 
 
Preparation of Fatty Acid Enriched Media 
A. Preparation of fatty acids stock solution  
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The pure fatty acids are purchased from NuCheck (http://www.nu-chekprep.com 
/home.htm).  The stock solution is made in Hexane. 
1. Get fatty acid from the commercial container (100mg).   
Record the weight of fatty acid and the molecular weight. Make a 5 ml solution in 
graduated flask and then calculate the final concentration: N1 
X mg × 1000 
5 ml × MW  
Result is in unit as mM. 
2. Fill the graduated flask with gas N2 and carefully sealed with parafilm.   
 
B. Fatty acids Media preparation  
Fatty acid will be prepared in M199 enriched with 5% (v/v) FBS. Assuming the 
100% serum has an average concentration of albumin at 600 μM, then the 5% FBS 
will give us up to 30 μM albumin. The ratio of free fatty acids to albumin should not 
exceed 3 to 1, otherwise fatty acid is toxic to cells. So, for a 5% FBS media, the 
highest fatty acid concentration can achieve is around 90 μM. 
1. For 10ml plate, if the final conc. of fatty acid is 20 μM (0.02 mM), we need to 
calculate how much fatty acid solution in hexane we will need. V1 
Set 1 as stock solution, 2 as experimental solution: 
V1N1=V2N2 
X×N1 =10×0.02 
      10×0.02 
X=      N1 
X is in the unit of μl 
 
2. For 12 100 ml plates, we will need 120ml media. Always prepare extra 5 ml, 
because we will need to filter the media and later which can cause the lost of 
some volume. 
After finishing the calculation, take a glass tube put NaOH 30 times exceed of FA 
concentration. Volume of 6 N NaOH: V3 
FA conc.×30× V2 
6  
Put NaOH (V3) in a culture glass tube, then add FA (V1).  
Carefully blow in the gas N2 for 15 min to 30 min until it totally dried (white powder).  
3. Wash out FA from glass tubes into the media (V2). 
Adjust pH of the media to 7.4 with HCl. 
4. Filtration through the syringe filter or bottle filter (0.02 μm) then add to the cells. 
Oxidative Stress Measurement 
1. Grow cells in microplates (12, 24 or 48) well plates.  Include a control groups to be 
used as negative and positive controls. 
2. Wash cells at least two or three times with Hanks buffer to remove serum. 
3. Add KREBS-Ringer-Glucose buffer containing DCF (100 μmol/L) to microplates.  
Use 1ml for 12 wells and 0.5 ml for 24 wells and incubate for 30 minutes.  Blank well 
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receives KREBS-Ringer-Glucose buffer without DCF probe.  Wrap plate in aluminum 
foil to protect from the light. 
4. Wash 2 to 3 times with HEPES buffer. 
5. Add HEPES to each well (1 ml for 12 well plates and 0.5 ml for 24 well plates.  Wrap 
plate in aluminum foil. 
Optional: Positive control receives 0.1 mmol/L H2O2 in HEPES buffer after DCF staining. 
6. Set plate reader excitation to λ 490 nm and emission to λ 520 and/or 530 nm.   
Light sensitive reactions: protect stocks from light by wrapping in aluminum foil when 
adding DCF media on cells, switch off the light in the hood. 
Buffers and solutions: 
HEPES buffer (500ml pH 7.4): 
NaCl: 4.237g 
KCl: 186.4mg 
MgCl2: 50.8mg 
D-glucose: 901.0mg 
HEPES: 1.1915g 
CaCl2: 110.25mg 
KREBS-Ringer-Glucose Buffer: 
Components To make 1 L To make 500 ml 
118 mM NaCl 6.9 g 3.448 g 
4.7 mM KCl 0.35 g 0.175 g 
1.3 mM CaCl2 0.191 g 0.096 g 
12.0 mM MgCl2 2.375 g 1.187 g 
1 mM NaH2PO4H2O 0.138 g 0.069 g 
25 mM NaHCO3 2.1 g 1.050 g 
11mM Glucose 1.982 g 0.991 g 
DCF stock solution: 
To make the DCF stock solution mix 9.7458 mg of DCF with 1 ml of DMSO.  The 
DCF concentration in the stock is 20 mM. 
Note on DCF stock: 20mM in EtOH or DMSO, MW of DCF 487.29g.   
To make the DCF working solution, add 125 μl of the stock and complete volume to 
25 ml with KREBS buffer.  The DCF concentration in the working solution should be 
100 μM. 
Fluorescent plate reader settings: 
Softmax Pro 3.1.2 
Set up wavelength: 
 Sensitivity: 15 
 Auto Calibrate: on 
 Strip 
Template: set blank at 0, or set all samples. 
 
 
PGE2 EIA kit 
Plate cells: 
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Small plates will be used, so that the protein level of COX-2 and mPGE synthase can 
be measured. 
Supernatants of cell cultures will be mixed well then collected 1 ml directly into 
Eppendorf’s tubes.  Store at -80 C.  In the day of measurement, thaw the samples, mix 
well then centri at 4C 12000rpm for 10 min.  
 
Using the Kit: 
Condition preparation: for the first time to use the kit. Make standard curve dilution 
in 5% medium (the four highest ones). And one control and one TNF-α treatment sample 
to check whether it’s within the range of standard curve. 
 
Key terms: 
Blank: background absorbance caused by Ellman’s reagent. 
Total activity: total enzymatic activity of the AchE-linked tracer. 
Non-specific binding (NSB): non-immunological binding of the tracer to the well. 
Maximum binding (B0): maximum amount of the tracer that the antibody can bind 
in the absence of free analyte. 
% bound/ maximum bound (%B/B0): ratio of the absorbance of a particular sample 
or standard well to that of the maximum binding. 
Standard curve: a plot of the %B/B0 values versus concentration of a series of wells 
containing various known amounts of analyte. 
A.  Pre-assay preparation: 
Buffer preparation (all stored at 4C, will be stable for ~2 months) 
1. EIA buffer: dilute one vial of EIA buffer (vial #4) with 90 ml of Ultrapure water. 
Rinse the vial well. 
2. Wash buffer: dilute 5 ml vial of Wash buffer (vial #5) to a total volume of 2 liters 
with Ultrapure water and add 1 ml of Tween 20 (vial #5a) use a syringe. 
 
Wash buffer (vial #5) Ultrapure water  
(1:400 of wash buffer) 
Tween 20 (vial #5a)  
(0.5ml/liter wash buffer) 
5ml 2 L 1ml 
12.5ml 5 L 2.5ml 
 
 
 
Collecting samples 
Cell culture supernatants may be assayed directly. If the PGE2 concentration in the 
medium is high enough to dilute the sample 10-fold with EIA buffer, the assay can be 
performed without any modifications. When assaying less concentrated samples 
(where samples cannot be diluted with EIA buffer), dilute the standard curve in the 
same culture medium as that used in the experiment. This will ensure that the matrix 
for the standards is comparable to the samples. A standard curve is recommended to 
be run first to ensure that the assay will perform in a particular medium. 
B.  Preparation of assay-specific reagents 
1. PGE2 standard 
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Reconstitute the contents of the PGE2 standard with 1 ml of EIA buffer. The 
concentration of this solution (the bulk standard) will be 10 ng/ml. Stored at 4C; this 
standard will be stable for up to 4 weeks.  
NOTE: if assaying culture medium samples that have not been diluted with EIA buffer, 
culture medium should be used in place of EIA buffer for dilution of the standard curve. 
The diluted standards should not be stored for more than 24 hr. 
2. PGE2 AChE tracer: Will be used twice in the two days measurement. Always 
keep the rest. 
Reconstitute the 100 dtn PGE2 tracer (vial #2) with 6 ml EIA buffer. Store the 
reconstituted PGE2 tracer at 4C (DO NOT FREEZE!) and use within 2 weeks.  
Tracer Dye Instructions: this dye may be added to the tracer, if desired, to aid in 
visualization of tracer-containing wells. Add the dye to the reconstituted tracer at a final 
dilution of 1:100 (add 60 μl of dye to 6 ml tracer or add 300 μl of dye to 30 ml of tracer). 
3. PGE2 monoclonal antibody: 
Reconstitute the 100 dtn PGE2 antibody (vial #1) with 6 ml EIA buffer. Store the 
reconstituted PGE2 antibody at 4 C. it will be stable for at least 4 weeks. 
Antiserum dye instructions: this dye may be added to the antiserum, if desired, to aid 
in visualization of antiserum-containing wells. Add the dye to the reconstituted antiserum 
at a final dilution of 1:100 (add 60 μl of dye to 6 ml antiserum). 
 
C.  Performing the assay 
1.   Plate set up 
 
It is not necessary to rinse the plate prior to adding the reagents. If strip plate, place 
the unused strips back in the plate packet and store at 2-4C. Be sure the packet is sealed 
with the desiccant inside. 
 
Each set of strips must contain a minimum of two blanks (Blk), two non-specific 
binding wells (NSB), two maximum binding wells (B0), and an eight point standard 
curve run in duplicate. Each sample should be assayed at two dilutions and each dilution 
should be assayed in duplicate. For statistical purposes, we recommend assaying samples 
in triplicate. 
2.  Pipet the reagents: 
Before pipetting each reagent, equilibrate the pipet tip in that reagent (slowly fill the 
tip and gently expel the contents, repeat several times). 
EIA buffer:  
Add 100 μl EIA buffer to Non-specific binding (NSB) wells.  
Add 50 μl EIA buffer to Maximum binding (B0) wells.  
Or: If culture medium was used to dilute the standard curve, substitute 50 μl of 
culture medium for EIA buffer in the NSB and B0 wells: 
Add 50 μl culture medium and 50 μl of EIA buffer to NSB wells. 
Add 50 μl culture medium to B0 wells. 
PGE2 standard: 
Add 50 μl from tube #8 to both of the lowest standard wells (S8). 
Add 50 μl from tube #7 to each of the next two standard wells (S7). 
Continue with this procedure until all the standards are aliquoted. 
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The same pipet tip should be used to aliquot all the standards. Before pipetting each 
standard, be sure to equilibrate the pipet tip in that standard. 
Samples: 
Add 50 μl of sample per well. Each sample should be assayed at a minimum of two 
dilutions. Each dilution should be assayed in duplicate (triplicate recommended). 
PGE2 AChE tracer: 
Add 50 μl to each well except the total activity (TA) and the blank (Blk) wells. 
PGE2 Monoclonal antibody: 
Add 50 μl to each well except the Total Activity (TA), the Non-Specific Binding 
(NSB), and the Blank (Blk) wells. 
Incubate the plate: 
Cover each plate with plastic film and incubate 18 hr at 4C. 
Develop the plate: 
When ready to develop the plate, reconstitute one 100 dtn vial of Ellman’s Reagent 
(vial #8) with 20 ml of UltraPure water. Reconstitute Ellman’s Reagent is unstable and 
should be used the same day it is prepared; protect the Ellman’s Reagent from light when 
not in use. 
Empty the wells and rinse five times with Wash Buffer. Add 200 ml of Ellman’s 
Reagent to each well and 5 ml of tracer to the Total Activity wells. Cover the plate with 
plastic film. 
Optimum development is obtained by using an orbital shaker equipped with a large, 
flat cover to allow the plates to develop in the dark. This assay typically develops (i.e., 
B0 well ≥ 0.3 A.U.) in 60-90 minutes. 
Read the plate: 
Read the plate at a wavelength between 405-420 nm (405 was used). Before reading, 
wipe the bottom of the plate with a clean tissue to remove finger prints. The plate may be 
checked periodically until the B0 wells have reached a minimum of 0.3 A.U. the plate 
should be read when the absorbance of the B0 wells is n the range of 0.3-1.0 A.U. If the 
absorbance of the wells exceeds 1.5, wash the plate, add fresh Ellman’s Reagent and let it 
develop again. 
 
Immunofluorescence 
Plate cells (100μl cells plus 300μl Medium)onto glass chamber slides leaving room for 3 
extra controls (IgG, no 1°, no 1° or 2°), grow to confluence, serum starve overnight. Then 
start the treatment. 
1) Remove media from wells. 
2) Depends on antigen of interest, could fix with: 
a). 500 μL of 50:50 acetone/methanol solution for 30 minutes at RT; 
b). 500 μL of methanol for 15 min at RT; 
c). 500 μL of 4% paraformaldehyde in PBS for 1hr.  Would need to quench with   
                     0.3M/ (made a 0.2M) glycine for 10 min. 
During the fixation, turn on the heater to 37C on the shaker. 
3) Wash with 1x PBS 3x for 5 minutes at 37°C shaking. 
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4) Depending on antigen, permealize with 0.2% Triton X 100 in 1x PBS for 15 min at 
37°C shaking (could use less if unsure 0.01%) 
5) Wash with 1x PBS 3x for 5 minutes at 37°C shaking 
6) At this step you can put the slide in the fridge, wrapped in parafilm, before going on. 
 
The second day: 
7) Heat slide back up if stopped. 
8) Block with 500 μL of a solution of 15 μL/mL of the serum of the secondary in 1% 
BSA (0.1g BSA in 9.9ml 1x PBS) in 1x PBS for 45 minutes at 37°C shaking.  
 
Protein of interest Secondary Ab  Serum of the 2nd Ab Dye (color) 
Cav-1 (mouse) Donkey anti-mouse  Donkey (7.5μL in 
500μL/well) 
Green 
TNF-receptor 1 (goat) Donkey anti-goat Donkey (7.5μL in 
500μL/well) 
Orange 
 
9) Without washing, put the respective primaries on the indicated wells diluted in 1x 
PBS.  Add corresponding IgG to the control well allotted at the same concentration as 
your primary (ex. 5 μg/mL) for 30 minutes at 37°C shaking. 
 
Protein of interest Primary Ab conc. (dilution in 1x PBS) 
Cav-1 (mouse) Mouse-200μg/ml. 
(need a 40x dilution: 1.25μl into 500μl PBS) 
TNF-receptor 1 (goat) Goat-100μg/ml. 
(need a 20x dilution: 25μl into 500μl PBS) 
 
10) Wash the wells 2x in 1x PBS, then an additional 1x for 5 minutes at 37°C shaking 
11) Avoiding light, add the secondary antibody (ex. 1/200) diluted in 1x PBS for 15 
minutes at 37°C shaking covered in aluminum foil.  
 
 
Protein of interest 2nd Ab conc. (dilution in 1x PBS) Dye 
(co
lor)
Cav-1 (mouse) Alexa Fluor 488 Donkey anti-mouse: 2mg/ml 
(need a 1/200 dilution: 2.5μl into 500μl PBS) 
Green 
TNFRI (goat) AlexaFluor 546 donkey anti-goat: 2mg/ml 
(need a 1/200 dilution: 2.5μl into 500μl PBS) 
Orange
 
12) Wash the well 2x in 1x PBS, and then an additional 1x for 5 minutes at 37°C shaking 
13) Add Hoechst stain at a concentration of 1 μg/mL (add 0.5μl into 500μl from the 
1mg/ml Hoechst solution) for 5-10 minutes at 37°C shaking. 
14) Wash the wells 3x in 1x PBS, then pull off the sides of the wells. Mount with one 
drop of VectaMount and covered with large cover slides avoid bubbles. Use nail 
polish to seal the sides. Store at 4°C in foil. 
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Confocal Microscopy 
A. Turn on the machine: 
From the right side to the 1eft side and then right again, last is the Middle. 
1. Right side: Burner 
2. Left: Laser black switch and turn the key, then turn on the Green and Red lasers. 
3. Right: LD laser 
4. Middle: Up LG-PS2 
          Middle: BX-UCB 
          Lower: FV5 
Let the machine warm up for 10 min before start experiment.  
Only when the FV5-PSU on, the laser can be turn on.  FV5-LDPSU has a safety knob 
switch, need to be on all the time.  
 
B. Adjust the focus of samples and check the dye by switch light path 1 through 5 by 
microscope. 
Our system is having 2 channels and 4 filters. Switch the filter on the left side of the 
machine. 
If use 60X, must use a drop of oil between the projector and the slide. 
Use the up baton on the right lower side of the microscope to make the length at the 
proper position.  
When check different dye, use the respective filter. Shut off the shutter after each 
check in order to avoid the quencher of the slide.  
 
C. After ready for taking pictures, switch the light path to 1 (clear light). And pull out 
the camera light path on the right side of microscope.   
 
First clear the dye selection then add preferred dyes on the middle of the screen. 
APPLY 
The lower mirror set to an empty one. 
Active the laser filters on the left lower part of the screen. 
1.  DAPI: blue color. Dark pink laser. DAPI is Hoechst, Blue color. Channel 1, A in 
B out. (LD405) 
2.  FITC: green. Blue laser.  FITC is green. (AR488) 
3.  TEX red. 
 
On the left side of the channel and filter switch, a black bar is for the setting of how 
much light goes to each channel.  
For DAPI set the black bar to the middle position and for FITC, pull the black bar all 
the way out.  
There is a round bigger turning, can adjust the signal. 
Try the ONCE scanning first to see how the picture is.  
To clean up the image, always keep the Gain low at 1 and increase the PMT (voltage) 
to get stronger signals. 
Don’t increase the laser adjusting on the left lower part of the screen, because 
increase the density of laser is bad for the sample. 
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Can also try the XYREPEAT and adjust the focus at the same time to choose better 
image. 
The type of scanning:  
I. Normal, can give only one picture each time. 
II. Sequence: can add channel, and do a continuous scanning with different dye 
settings. Optical Syst. Group 4. Add channel, click on optical system, add DPSI or 
FITC. 
 
Click on the icon: --Δ 
                Δ--- which is “scan unit configuration”. Set FITC (green) and Mito (red) to 
group I, and DAPI to group II.  Sequence: once. 
                 
The three-color bar can be used to change the image from different channel. One 
group can include 2 channels.  
 
Detergent-free Purification of Caveolin Enriched Membrane Fractios (Sucrose 
Gradient) 
1.  Cells were plated in 4 100 mm plate/treatment.  Cells were washed with 1x PBS and 
lysed with 2 ml of ice-cold MES-buffered saline (MBS; 25mM MES 
(morpholineethanesulfonic acid, pH 6.5) 150 mM NaCl) containing 500 mM Na2CO3.   
For the preparation:  
25 mM MES: 2.4405 g in 500 ml water. Adjust PH to 6.5. 
Then add 4.383g NaCl into MES, achieve MBS. 
Take 50 ml MBS, add 2.65g Na2CO3, get 500mM. this is lysis buffer. 
90% Sucrose: 45g sucrose and make final volume 50 ml. Heat in water bath to 
dissolve. 
35% Sucrose: 17.5 g sucrose and final volume 50 ml. 
5% sucrose: 2.5 g sucrose and final volume 50 ml. 
 
2.  Homogenation was carried out with 10 strokes of a loose-fitting Dounce homogenizer 
(7ml).  After homogenized, get samples into 15ml cornival tubes for sonication: 30 
sec. for 10 times on ice.  The setting is 4 and 60.  The frequency should be under 20. 
3.  After sonication, centrifuge at 3000 rpm for 10 min at 4C.   
4.  Collect superant into centrifuge tubes (14x89mm), if its not exactly 2 ml, add more 
MBS to reach 2 ml. 
5.  The homogenate was adjusted to 45% sucrose by addition of 2 ml of 50ml 90% 
sucrose prepared in MBS and placed at the bottom of an ultracentrifuge tube, and 
overlaid with a discontinuous sucrose gradient  
Add 2 ml 90% sucrose to make the final 45% sucrose (cut off the top of the tip), add 
into tube slowly against walls, then vortex to mix well. 
6.  Add 5 ml of 35% sucrose. Use 1 ml peppit five times. The first 1 and 2 ml must be 
very slow, add drop by drop to avoid interrupt layers. After the 3rd ml, can be a little 
faster. 
7.  Add 3 ml of 5% sucrose. Then the tube is pretty full. 
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8.  Measure weight of the 2 or 4 tubes (depends on sample number), put the one with 
more volume first on the scale, set to 0. then put the less volume ones. Achieve 0 with 
5% sucrose. At least the 3 digital. 
9.  Get the rotor from 4C. Centrifuge 39000 rpm for 16 h. 
10.  The second day morning, collect fractions into 1.5ml clear tubes. Label 1 to 12. can 
see a white fraction which is Cav-1 enriched faction. Sometime the 12th fraction has a 
little bit less or more volume.  
11. Run the gel. Jin: 16 μl + 4 μl 5x loading buffer. 
                          Lei: 15 μl + 3 μl 6x loading buffer. 
Run the gel for 12 fractions on each western blot gel. 
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